Localized	O
pancreatic	O
NF-kappaB	O
activation	O
and	O
inflammatory	O
response	O
in	O
taurocholate-induced	O
pancreatitis	O
.	O

Transcription	B-protein
factor	I-protein
nuclear	I-protein
factor-kappaB	I-protein
(	O
NF-kappaB	B-protein
)	O
is	O
activated	O
in	O
cerulein	O
pancreatitis	O
and	O
mediates	O
cytokine	O
expression	O
.	O

The	O
role	O
of	O
transcription	O
factor	O
activation	O
in	O
other	O
models	O
of	O
pancreatitis	O
has	O
not	O
been	O
established	O
.	O

Here	O
we	O
report	O
upregulation	O
of	O
NF-kappaB	B-protein
and	O
inflammatory	B-protein
molecules	I-protein
,	O
and	O
their	O
correlation	O
with	O
local	O
pancreatic	O
injury	O
,	O
in	O
a	O
model	O
of	O
severe	O
pancreatitis	O
.	O

Rats	O
received	O
intraductal	O
infusion	O
of	O
taurocholate	O
or	O
saline	O
,	O
and	O
the	O
pancreatic	O
head	O
and	O
tail	O
were	O
analyzed	O
separately	O
.	O

NF-kappaB	B-protein
and	O
activator	B-protein
protein-1	I-protein
(	O
AP-1	B-protein
)	O
activation	O
were	O
assessed	O
by	O
gel	O
shift	O
assay	O
,	O
and	O
mRNA	O
expression	O
of	O
interleukin-6	B-RNA
,	O
tumor	B-protein
necrosis	I-protein
factor-alpha	I-protein
,	O
KC	O
,	O
monocyte	B-protein
chemoattractant	I-protein
protein-1	I-protein
,	O
and	O
inducible	B-protein
nitric	I-protein
oxide	I-protein
synthase	I-protein
was	O
assessed	O
by	O
semiquantitative	O
RT-PCR	O
.	O

Morphological	O
damage	O
and	O
trypsin	O
activation	O
were	O
much	O
greater	O
in	O
the	O
pancreatic	O
head	O
than	O
tail	O
,	O
in	O
parallel	O
with	O
a	O
stronger	O
activation	O
of	O
NF-kappaB	B-RNA
and	I-RNA
cytokine	I-RNA
mRNA	I-RNA
.	O

Saline	O
infusion	O
mildly	O
affected	O
these	O
parameters	O
.	O

AP-1	B-protein
was	O
strongly	O
activated	O
in	O
both	O
pancreatic	O
segments	O
after	O
either	O
taurocholate	O
or	O
saline	O
infusion	O
.	O

NF-kappaB	B-protein
inhibition	O
with	O
N-acetylcysteine	O
ameliorated	O
the	O
local	O
inflammatory	O
response	O
.	O

Correlation	O
between	O
localized	O
NF-kappaB	B-protein
activation	O
,	O
cytokine	O
upregulation	O
,	O
and	O
tissue	O
damage	O
suggests	O
a	O
key	O
role	O
for	O
NF-kappaB	B-protein
in	O
the	O
development	O
of	O
the	O
inflammatory	O
response	O
of	O
acute	O
pancreatitis	O
.	O

Am	NULL
J	NULL
Physiol	NULL
Gastrointest	NULL
Liver	NULL
Physiol	NULL
280	NULL
:	NULL
G1197-G1208	NULL
,	NULL
2001	NULL
.	NULL

Localized	NULL
pancreatic	NULL
activation	NULL
and	NULL
inflammatory	NULL
response	NULL
in	NULL
taurocholate-induced	NULL
pancreatitis	NULL
EVA	NULL
VAQUERO	NULL
,	NULL
ILYA	NULL
GUKOVSKY	NULL
,	NULL
VJEKOSLAV	NULL
ZANINOVIC	NULL
,	NULL
ANNA	NULL
S.	NULL
GUKOVSKAYA	NULL
,	NULL
AND	NULL
STEPHEN	NULL
J.	NULL
PANDOL	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Veterans	NULL
Affairs	NULL
Greater	NULL
Los	NULL
Angeles	NULL
Healthcare	NULL
System	NULL
and	NULL
the	NULL
University	NULL
of	NULL
California	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
California	NULL
90073	NULL
Received	NULL
29	NULL
June	NULL
2000	NULL
;	NULL
accepted	NULL
in	NULL
final	NULL
form	NULL
24	NULL
January	NULL
2001	NULL
Vaquero	NULL
,	NULL
Eva	NULL
,	NULL
Iya	NULL
Gukovsky	NULL
,	NULL
Vjekoslav	NULL
Zaninovic	NULL
,	NULL
Anna	NULL
S.	NULL
Gukovskaya	NULL
,	NULL
and	NULL
Stephen	NULL
J.	NULL
Pandol	NULL
.	NULL

Localized	NULL
pancreatic	NULL
NF-kB	NULL
activation	NULL
and	NULL
inflammatory	NULL
response	NULL
in	NULL
taurocholate-induced	NULL
pancreatitis	NULL
.	NULL

Am	NULL
J	NULL
Physiol	NULL
Gastrointest	NULL
Liver	NULL
Physiol	NULL
280	NULL
:	NULL
G1197-G1208	NULL
,	NULL
2001.-Transcription	NULL
factor	NULL
nuclear	NULL
factor-kB	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
is	NULL
activated	NULL
in	NULL
cerulein	NULL
pancreatitis	NULL
and	NULL
mediates	NULL
cytokine	NULL
expression	NULL
.	NULL

The	NULL
role	NULL
of	NULL
transcription	NULL
factor	NULL
activation	NULL
in	NULL
other	NULL
models	NULL
of	NULL
pancreatitis	NULL
has	NULL
not	NULL
been	NULL
established	NULL
.	NULL

Here	NULL
we	NULL
report	NULL
upregulation	NULL
of	NULL
NF-kB	NULL
and	NULL
inflammatory	NULL
molecules	NULL
,	NULL
and	NULL
their	NULL
correlation	NULL
with	NULL
local	NULL
pancreatic	NULL
injury	NULL
,	NULL
in	NULL
a	NULL
model	NULL
of	NULL
severe	NULL
pancreatitis	NULL
.	NULL

Rats	NULL
received	NULL
intraductal	NULL
infusion	NULL
of	NULL
taurocholate	NULL
or	NULL
saline	NULL
,	NULL
and	NULL
the	NULL
pancreatic	NULL
head	NULL
and	NULL
tail	NULL
were	NULL
analyzed	NULL
separately	NULL
.	NULL

NF-	NULL
«	NULL
kB	NULL
and	NULL
activator	NULL
protein-1	NULL
(	NULL
AP-1	NULL
)	NULL
activation	NULL
were	NULL
assessed	NULL
by	NULL
gel	NULL
shift	NULL
assay	NULL
,	NULL
and	NULL
mRNA	NULL
expression	NULL
of	NULL
interleukin-6	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor-	NULL
«	NULL
,	NULL
KC	NULL
,	NULL
monocyte	NULL
chemoattractant	NULL
protein-1	NULL
,	NULL
and	NULL
inducible	NULL
nitric	NULL
oxide	NULL
synthase	NULL
was	NULL
assessed	NULL
by	NULL
semiquantitative	NULL
RT-PCR	NULL
.	NULL

Morphological	NULL
damage	NULL
and	NULL
trypsin	NULL
activation	NULL
were	NULL
much	NULL
greater	NULL
in	NULL
the	NULL
pancreatic	NULL
head	NULL
than	NULL
tail	NULL
,	NULL
in	NULL
parallel	NULL
with	NULL
a	NULL
stronger	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
cytokine	NULL
mRNA	NULL
.	NULL

Saline	NULL
infusion	NULL
mildly	NULL
affected	NULL
these	NULL
parameters	NULL
.	NULL

AP-1	NULL
was	NULL
strongly	NULL
activated	NULL
in	NULL
both	NULL
pancreatic	NULL
segments	NULL
after	NULL
either	NULL
taurocholate	NULL
or	NULL
saline	NULL
infusion	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
inhibition	NULL
with	NULL
N-acetylcysteine	NULL
ameliorated	NULL
the	NULL
local	NULL
inflammatory	NULL
response	NULL
.	NULL

Correlation	NULL
between	NULL
localized	NULL
NF-kB	NULL
activation	NULL
,	NULL
cytokine	NULL
upregulation	NULL
,	NULL
and	NULL
tissue	NULL
damage	NULL
suggests	NULL
a	NULL
key	NULL
role	NULL
for	NULL
NF-kB	NULL
in	NULL
the	NULL
development	NULL
of	NULL
the	NULL
inflammatory	NULL
response	NULL
of	NULL
acute	NULL
pancreatitis	NULL
.	NULL

acute	NULL
pancreatitis	NULL
;	NULL
nuclear	NULL
factor-kB	NULL
;	NULL
activator	NULL
protein-1	NULL
;	NULL
cy-tokines	NULL
;	NULL
chemokines	NULL
;	NULL
inducible	NULL
nitric	NULL
oxide	NULL
synthase	NULL
ALTHOUGH	NULL
THE	NULL
MECHANISM	NULL
OF	NULL
acute	NULL
pancreatitis	NULL
has	NULL
not	NULL
been	NULL
established	NULL
,	NULL
there	NULL
is	NULL
emerging	NULL
evidence	NULL
that	NULL
upregulation	NULL
of	NULL
inflammatory	NULL
mediators	NULL
,	NULL
such	NULL
as	NULL
cytokines	NULL
,	NULL
chemokines	NULL
,	NULL
adhesion	NULL
molecules	NULL
,	NULL
and	NULL
inducible	NULL
nitric	NULL
oxide	NULL
synthase	NULL
(	NULL
iNOS	NULL
)	NULL
,	NULL
is	NULL
central	NULL
to	NULL
the	NULL
process	NULL
(	NULL
for	NULL
recent	NULL
reviews	NULL
,	NULL
see	NULL
Refs	NULL
.	NULL

6	NULL
,	NULL
36	NULL
,	NULL
and	NULL
43	NULL
)	NULL
.	NULL

Upregulation	NULL
of	NULL
these	NULL
molecules	NULL
has	NULL
been	NULL
shown	NULL
in	NULL
human	NULL
(	NULL
5	NULL
,	NULL
20	NULL
,	NULL
24	NULL
,	NULL
28	NULL
)	NULL
and	NULL
experimental	NULL
pancreatitis	NULL
(	NULL
11	NULL
,	NULL
12	NULL
,	NULL
16	NULL
,	NULL
17	NULL
,	NULL
38	NULL
,	NULL
39	NULL
,	NULL
41	NULL
,	NULL
48	NULL
,	NULL
52	NULL
)	NULL
,	NULL
and	NULL
their	NULL
role	NULL
in	NULL
the	NULL
disease	NULL
has	NULL
been	NULL
demonstrated	NULL
by	NULL
using	NULL
pharmacological	NULL
inhibitors	NULL
or	NULL
antagonists	NULL
(	NULL
17	NULL
,	NULL
21	NULL
,	NULL
35	NULL
,	NULL
37	NULL
,	NULL
41	NULL
,	NULL
47	NULL
)	NULL
,	NULL
neutralizing	NULL
antibodies	NULL
(	NULL
16	NULL
,	NULL
38	NULL
,	NULL
48	NULL
,	NULL
52	NULL
)	NULL
,	NULL
and	NULL
genetic	NULL
approaches	NULL
(	NULL
7	NULL
,	NULL
8	NULL
,	NULL
12	NULL
)	NULL
.	NULL

The	NULL
cellular	NULL
mechanism	NULL
of	NULL
regulation	NULL
of	NULL
these	NULL
inflammatory	NULL
molecules	NULL
involves	NULL
activation	NULL
of	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
nuclear	NULL
factor	NULL
(	NULL
8	NULL
,	NULL
14	NULL
,	NULL
51	NULL
)	NULL
and	NULL
activator	NULL
protein	NULL
(	NULL
AP	NULL
)	NULL
-1	NULL
(	NULL
50	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
in	NULL
the	NULL
pancreas	NULL
has	NULL
recently	NULL
been	NULL
demonstrated	NULL
in	NULL
rat	NULL
cerulein	NULL
pancreatitis	NULL
(	NULL
17	NULL
,	NULL
44	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
resulted	NULL
in	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
cytokines	NULL
KC	NULL
[	NULL
rat	NULL
analog	NULL
of	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
-8/Gro-	NULL
«	NULL
]	NULL
and	NULL
IL-6	NULL
(	NULL
17	NULL
)	NULL
.	NULL

NF-	NULL
<	NULL
B	NULL
and	NULL
AP-1	NULL
represent	NULL
two	NULL
early	NULL
response	NULL
tran-seriptional	NULL
complexes	NULL
essential	NULL
for	NULL
the	NULL
gene	NULL
expression	NULL
of	NULL
inflammatory	NULL
molecules	NULL
(	NULL
3	NULL
,	NULL
14	NULL
,	NULL
15	NULL
,	NULL
50	NULL
)	NULL
.	NULL

NF-KB	NULL
exists	NULL
as	NULL
a	NULL
complex	NULL
of	NULL
homo-	NULL
or	NULL
heterodimers	NULL
composed	NULL
of	NULL
members	NULL
of	NULL
the	NULL
Rel	NULL
family	NULL
of	NULL
proteins	NULL
(	NULL
3	NULL
,	NULL
14	NULL
)	NULL
.	NULL

In	NULL
most	NULL
resting	NULL
cells	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
sequestered	NULL
within	NULL
the	NULL
cytoplasm	NULL
in	NULL
an	NULL
inactive	NULL
form	NULL
.	NULL

After	NULL
activation	NULL
,	NULL
NF-kB	NULL
complexes	NULL
translocate	NULL
into	NULL
the	NULL
nucleus	NULL
and	NULL
activate	NULL
transcription	NULL
from	NULL
target	NULL
genes	NULL
.	NULL

AP-1	NULL
represents	NULL
a	NULL
homo-	NULL
or	NULL
heterodimer	NULL
complex	NULL
composed	NULL
of	NULL
Jun	NULL
,	NULL
Fos	NULL
,	NULL
or	NULL
activating	NULL
transcription	NULL
factor	NULL
subunits	NULL
(	NULL
22	NULL
,	NULL
49	NULL
)	NULL
.	NULL

These	NULL
components	NULL
normally	NULL
reside	NULL
in	NULL
the	NULL
nucleus	NULL
and	NULL
after	NULL
stimulation	NULL
bind	NULL
to	NULL
phorbol	NULL
ester-	NULL
or	NULL
cAMP-responsive	NULL
sites	NULL
on	NULL
DNA	NULL
,	NULL
inducing	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
involvement	NULL
of	NULL
the	NULL
inflammatory	NULL
molecules	NULL
and	NULL
their	NULL
regulation	NULL
has	NULL
mostly	NULL
been	NULL
investigated	NULL
in	NULL
rat	NULL
cerulein-induced	NULL
pancreatitis	NULL
,	NULL
a	NULL
model	NULL
with	NULL
mild	NULL
severity	NULL
(	NULL
1	NULL
,	NULL
26	NULL
)	NULL
.	NULL

To	NULL
establish	NULL
a	NULL
universal	NULL
role	NULL
for	NULL
these	NULL
mechanisms	NULL
in	NULL
the	NULL
development	NULL
of	NULL
pancreatitis	NULL
,	NULL
we	NULL
designed	NULL
the	NULL
present	NULL
set	NULL
of	NULL
experiments	NULL
in	NULL
a	NULL
model	NULL
of	NULL
pancreatitis	NULL
induced	NULL
in	NULL
rats	NULL
by	NULL
the	NULL
taurocholate	NULL
biliopancreatic	NULL
duct	NULL
infusion	NULL
.	NULL

This	NULL
model	NULL
is	NULL
associated	NULL
with	NULL
severe	NULL
pancreatic	NULL
necrosis	NULL
and	NULL
a	NULL
high	NULL
mortality	NULL
(	NULL
2	NULL
,	NULL
27	NULL
)	NULL
.	NULL

We	NULL
analyzed	NULL
early	NULL
molecular	NULL
events	NULL
,	NULL
namely	NULL
activation	NULL
of	NULL
inflammatory	NULL
molecules	NULL
[	NULL
IL-6	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
-	NULL
«	NULL
,	NULL
KC	NULL
,	NULL
monocyte	NULL
chemoattractant	NULL
protein	NULL
(	NULL
MCP	NULL
)	NULL
-1	NULL
,	NULL
and	NULL
iNOS	NULL
]	NULL
and	NULL
the	NULL
transcription	NULL
factors	NULL
involved	NULL
in	NULL
their	NULL
regulation	NULL
(	NULL
NF-	NULL
<	NULL
B	NULL
and	NULL
AP-1	NULL
)	NULL
.	NULL

In	NULL
the	NULL
taurocholate	NULL
model	NULL
,	NULL
pancreatic	NULL
damage	NULL
is	NULL
mainly	NULL
localized	NULL
to	NULL
the	NULL
head	NULL
of	NULL
the	NULL
pancreas	NULL
,	NULL
whereas	NULL
in	NULL
cerulein-induced	NULL
pancreatitis	NULL
and	NULL
other	NULL
models	NULL
the	NULL
Address	NULL
for	NULL
reprint	NULL
requests	NULL
and	NULL
other	NULL
correspondence	NULL
:	NULL
E.	NULL
Vaquero	NULL
,	NULL
VA	NULL
Greater	NULL
Los	NULL
Angeles	NULL
Healthcare	NULL
System	NULL
,	NULL
West	NULL
Los	NULL
Angeles	NULL
,	NULL
Bldg	NULL
.	NULL

258	NULL
,	NULL
Rm	NULL
.	NULL

331	NULL
,	NULL
11301	NULL
Wilshire	NULL
Blvd	NULL
.	NULL

,	NULL
Los	NULL
Angeles	NULL
,	NULL
CA	NULL
900783	NULL
(	NULL
E-mail	NULL
:	NULL
evaquero	NULL
@	NULL
ucla.edu	NULL
)	NULL
.	NULL

http	NULL
:	NULL
//www.ajpgi.org	NULL
0193-1857/01	NULL
$	NULL
5.00	NULL
Copyright	NULL
©	NULL
2001	NULL
the	NULL
American	NULL
Physiological	NULL
Society	NULL
The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

The	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

G1197	NULL
Downloaded	NULL
from	NULL
www.physiclogy.org/journal/ajpgi	NULL
(	NULL
173.236.240.127	NULL
)	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

G1198	NULL
damage	NULL
is	NULL
evenly	NULL
distributed	NULL
throughout	NULL
the	NULL
organ	NULL
.	NULL

Taking	NULL
advantage	NULL
of	NULL
this	NULL
characteristic	NULL
of	NULL
taurocholate-induced	NULL
pancreatitis	NULL
,	NULL
we	NULL
studied	NULL
the	NULL
early	NULL
molecular	NULL
events	NULL
separately	NULL
in	NULL
the	NULL
pancreatic	NULL
head	NULL
and	NULL
tail	NULL
and	NULL
correlated	NULL
them	NULL
with	NULL
the	NULL
local	NULL
morphological	NULL
and	NULL
biochemical	NULL
changes	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
neutrophil	NULL
infiltration	NULL
and	NULL
trypsin	NULL
activation	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
because	NULL
several	NULL
factors	NULL
(	NULL
chemical	NULL
and	NULL
mechanical	NULL
effect	NULL
,	NULL
oxidative	NULL
stress	NULL
,	NULL
ischemia-reperfusion	NULL
;	NULL
see	NULL
Refs	NULL
.	NULL

2	NULL
,	NULL
25	NULL
,	NULL
31	NULL
,	NULL
45	NULL
)	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
mechanism	NULL
of	NULL
this	NULL
model	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
pancreatic	NULL
response	NULL
to	NULL
saline	NULL
intraductal	NULL
infusion	NULL
,	NULL
in	NULL
which	NULL
the	NULL
trigger	NULL
is	NULL
restricted	NULL
to	NULL
increased	NULL
hydrostatic	NULL
pressure	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
injury	NULL
induced	NULL
by	NULL
saline	NULL
infusion	NULL
may	NULL
have	NULL
a	NULL
direct	NULL
clinical	NULL
implication	NULL
for	NULL
understanding	NULL
the	NULL
acute	NULL
pancreatitis	NULL
that	NULL
some	NULL
patients	NULL
develop	NULL
as	NULL
a	NULL
complication	NULL
of	NULL
the	NULL
endoscopic	NULL
retrograde	NULL
cholangiopancreatography	NULL
(	NULL
18	NULL
,	NULL
29	NULL
)	NULL
.	NULL

We	NULL
found	NULL
localized	NULL
activation	NULL
of	NULL
NF-kB	NULL
(	NULL
but	NULL
not	NULL
AP-1	NULL
)	NULL
and	NULL
localized	NULL
upregulation	NULL
of	NULL
inflammatory	NULL
molecules	NULL
in	NULL
the	NULL
pancreatic	NULL
head	NULL
.	NULL

These	NULL
molecular	NULL
changes	NULL
correlated	NULL
with	NULL
the	NULL
severity	NULL
of	NULL
morphological	NULL
changes	NULL
,	NULL
including	NULL
inflammatory	NULL
cell	NULL
infiltration	NULL
,	NULL
and	NULL
with	NULL
trypsin	NULL
activation	NULL
.	NULL

Moreover	NULL
,	NULL
pharmacological	NULL
blockade	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
resulted	NULL
in	NULL
attenuation	NULL
of	NULL
the	NULL
local	NULL
inflammatory	NULL
response	NULL
.	NULL

Saline	NULL
infusion	NULL
caused	NULL
,	NULL
although	NULL
to	NULL
a	NULL
lesser	NULL
degree	NULL
,	NULL
characteristic	NULL
morphological	NULL
changes	NULL
of	NULL
pancreatitis	NULL
and	NULL
NF-kB	NULL
and	NULL
AP-1	NULL
activation	NULL
and	NULL
upregulation	NULL
of	NULL
inflammatory	NULL
molecules	NULL
.	NULL

The	NULL
results	NULL
indicate	NULL
that	NULL
taurocholate	NULL
infusion	NULL
causes	NULL
a	NULL
localized	NULL
activation	NULL
of	NULL
NF-	NULL
<	NULL
B	NULL
that	NULL
,	NULL
in	NULL
turn	NULL
,	NULL
upregulates	NULL
the	NULL
expression	NULL
of	NULL
inflammatory	NULL
molecules	NULL
.	NULL

These	NULL
signals	NULL
may	NULL
be	NULL
important	NULL
for	NULL
the	NULL
infiltration	NULL
of	NULL
inflammatory	NULL
cells	NULL
and	NULL
localized	NULL
parenchymal	NULL
damage	NULL
in	NULL
pancreatitis	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Materials	NULL
Ketamine	NULL
hydrochloride	NULL
was	NULL
from	NULL
Fort	NULL
Dodge	NULL
Laboratories	NULL
(	NULL
Fort	NULL
Dodge	NULL
,	NULL
IA	NULL
)	NULL
,	NULL
and	NULL
xylazine	NULL
was	NULL
from	NULL
Miles	NULL
(	NULL
Shawnee	NULL
Mission	NULL
,	NULL
KS	NULL
)	NULL
;	NULL
Boc-Gln-Ala-Arg-7-amido-4-methylcoumarin	NULL
(	NULL
AMC	NULL
)	NULL
was	NULL
from	NULL
Bachem	NULL
(	NULL
Torrance	NULL
,	NULL
CA	NULL
)	NULL
;	NULL
PE-50	NULL
tubing	NULL
was	NULL
from	NULL
Becton-Dickinson	NULL
(	NULL
Sparks	NULL
,	NULL
MD	NULL
)	NULL
;	NULL
trypsin	NULL
was	NULL
from	NULL
Worthington	NULL
(	NULL
Freehold	NULL
,	NULL
NJ	NULL
)	NULL
;	NULL
MES	NULL
was	NULL
from	NULL
ICN	NULL
Biomedicals	NULL
(	NULL
Aurora	NULL
,	NULL
OH	NULL
)	NULL
;	NULL
Tissue-Tek	NULL
optimum	NULL
cutting	NULL
temperature	NULL
(	NULL
OCT	NULL
)	NULL
compound	NULL
was	NULL
from	NULL
Sakura	NULL
Finetek	NULL
(	NULL
Torrance	NULL
,	NULL
CA	NULL
)	NULL
;	NULL
polyclonal	NULL
rabbit	NULL
anti-rat	NULL
neutrophil	NULL
antibody	NULL
was	NULL
from	NULL
Accurate	NULL
Chemical	NULL
and	NULL
Science	NULL
(	NULL
Westbury	NULL
,	NULL
NY	NULL
)	NULL
;	NULL
antibodies	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
and	NULL
the	NULL
avidin-biotin	NULL
complex	NULL
(	NULL
ABC	NULL
)	NULL
]	NULL
peroxidase	NULL
staining	NULL
kit	NULL
were	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
San-ta	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
;	NULL
TRIzol	NULL
reagent	NULL
and	NULL
the	NULL
SuperScript	NULL
II	NULL
Preamplification	NULL
System	NULL
were	NULL
from	NULL
GIBCO-BRL	NULL
(	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
;	NULL
Exo	NULL
(	NULL
-	NULL
)	NULL
Klenow	NULL
DNA	NULL
polymerase	NULL
I	NULL
was	NULL
from	NULL
Stratagene	NULL
(	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
;	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
was	NULL
from	NULL
Boehringer-Mannheim	NULL
(	NULL
Indianapolis	NULL
,	NULL
IN	NULL
)	NULL
;	NULL
Bio-Rad	NULL
protein	NULL
assay	NULL
was	NULL
from	NULL
Bio-Rad	NULL
Laboratories	NULL
(	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Other	NULL
reagents	NULL
were	NULL
from	NULL
Sigma	NULL
Chemical	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

Experimental	NULL
Procedure	NULL
Care	NULL
and	NULL
handling	NULL
of	NULL
the	NULL
animals	NULL
were	NULL
approved	NULL
by	NULL
the	NULL
Animal	NULL
Research	NULL
Committee	NULL
of	NULL
the	NULL
Veterans	NULL
Affairs	NULL
Greater	NULL
Los	NULL
Angeles	NULL
Healthcare	NULL
System	NULL
,	NULL
in	NULL
accordance	NULL
with	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
guidelines	NULL
.	NULL

Male	NULL
Sprague-Dawley	NULL
rats	NULL
(	NULL
Harlan	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
,	NULL
weighing	NULL
300-340	NULL
g	NULL
,	NULL
were	NULL
random	NULL
NF-KB	NULL
ACTIVATION	NULL
IN	NULL
TAUROCHOLATE	NULL
PANCREATITIS	NULL
ized	NULL
into	NULL
different	NULL
groups	NULL
and	NULL
fasted	NULL
overnight	NULL
before	NULL
the	NULL
experiment	NULL
.	NULL

Acute	NULL
taurocholate	NULL
pancreatitis	NULL
was	NULL
induced	NULL
according	NULL
to	NULL
Aho	NULL
et	NULL
al	NULL
.	NULL

(	NULL
2	NULL
)	NULL
.	NULL

Under	NULL
a	NULL
combination	NULL
of	NULL
xylazine	NULL
(	NULL
10	NULL
mg/kg	NULL
)	NULL
and	NULL
ketamine	NULL
(	NULL
100	NULL
mg/kg	NULL
)	NULL
anesthesia	NULL
,	NULL
a	NULL
midline	NULL
lap-arotomy	NULL
was	NULL
performed	NULL
and	NULL
a	NULL
PE-50	NULL
catheter	NULL
(	NULL
inside	NULL
diameter	NULL
0.58	NULL
mm	NULL
,	NULL
outside	NULL
diameter	NULL
0.96	NULL
mm	NULL
)	NULL
was	NULL
inserted	NULL
in	NULL
the	NULL
pancreatic	NULL
duct	NULL
through	NULL
a	NULL
puncture	NULL
of	NULL
the	NULL
duodenum	NULL
.	NULL

The	NULL
biliopancreatic	NULL
duct	NULL
was	NULL
occluded	NULL
transiently	NULL
by	NULL
a	NULL
silk	NULL
ligature	NULL
at	NULL
the	NULL
liver	NULL
hilus	NULL
to	NULL
prevent	NULL
regurgitation	NULL
of	NULL
the	NULL
infusate	NULL
into	NULL
the	NULL
liver	NULL
.	NULL

Sodium	NULL
taurocholate	NULL
solution	NULL
(	NULL
0.4	NULL
ml	NULL
of	NULL
4	NULL
%	NULL
;	NULL
TC	NULL
group	NULL
)	NULL
or	NULL
the	NULL
same	NULL
volume	NULL
of	NULL
saline	NULL
(	NULL
saline	NULL
group	NULL
)	NULL
was	NULL
retrogradely	NULL
infused	NULL
in	NULL
the	NULL
pancreatic	NULL
duct	NULL
at	NULL
a	NULL
flow	NULL
rate	NULL
of	NULL
0.07	NULL
ml/min	NULL
by	NULL
a	NULL
microinfusion	NULL
pump	NULL
.	NULL

At	NULL
the	NULL
completion	NULL
of	NULL
the	NULL
infusion	NULL
,	NULL
the	NULL
catheter	NULL
and	NULL
hilar	NULL
ligature	NULL
were	NULL
removed	NULL
and	NULL
the	NULL
abdomen	NULL
was	NULL
closed	NULL
with	NULL
suture	NULL
.	NULL

Intact	NULL
rats	NULL
served	NULL
as	NULL
a	NULL
control	NULL
(	NULL
control	NULL
group	NULL
)	NULL
.	NULL

To	NULL
inhibit	NULL
NF-kB	NULL
activation	NULL
,	NULL
rats	NULL
from	NULL
the	NULL
TC	NULL
group	NULL
received	NULL
,	NULL
in	NULL
addition	NULL
,	NULL
an	NULL
intravenous	NULL
bolus	NULL
of	NULL
200	NULL
mg/kg	NULL
N-acetylcysteine	NULL
(	NULL
NAC	NULL
)	NULL
in	NULL
saline	NULL
2	NULL
h	NULL
before	NULL
intraductal	NULL
infusion	NULL
of	NULL
taurocholate	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
continuous	NULL
intravenous	NULL
infusion	NULL
of	NULL
NAC	NULL
(	NULL
25	NULL
mg-kg	NULL
'th	NULL
'	NULL
)	NULL
.	NULL

Controls	NULL
received	NULL
an	NULL
intravenous	NULL
saline	NULL
infusion	NULL
at	NULL
the	NULL
same	NULL
rate	NULL
.	NULL

These	NULL
groups	NULL
of	NULL
rats	NULL
were	NULL
killed	NULL
6	NULL
h	NULL
after	NULL
taurocholate	NULL
ad-ministration	NULL
.	NULL

At	NULL
1	NULL
or	NULL
6	NULL
h	NULL
after	NULL
taurocholate	NULL
infusion	NULL
,	NULL
animals	NULL
were	NULL
killed	NULL
by	NULL
CO	NULL
;	NULL
asphyxiation	NULL
and	NULL
blood	NULL
was	NULL
obtained	NULL
in	NULL
heparinized	NULL
tubes	NULL
for	NULL
amylase	NULL
and	NULL
lipase	NULL
determinations	NULL
.	NULL

Portions	NULL
of	NULL
the	NULL
pancreas	NULL
were	NULL
immediately	NULL
removed	NULL
,	NULL
trimmed	NULL
of	NULL
fat	NULL
,	NULL
rinsed	NULL
in	NULL
ice-cold	NULL
PBS	NULL
,	NULL
snap	NULL
frozen	NULL
in	NULL
liquid	NULL
nitrogen	NULL
,	NULL
and	NULL
stored	NULL
at	NULL
-80°C	NULL
until	NULL
processing	NULL
for	NULL
active	NULL
trypsin	NULL
measurements	NULL
,	NULL
nuclear	NULL
protein	NULL
extraction	NULL
,	NULL
and	NULL
RNA	NULL
isolation	NULL
.	NULL

Portions	NULL
of	NULL
the	NULL
gland	NULL
were	NULL
also	NULL
saved	NULL
for	NULL
morphological	NULL
examination	NULL
.	NULL

Specimens	NULL
of	NULL
the	NULL
head	NULL
and	NULL
tail	NULL
segments	NULL
of	NULL
the	NULL
pancreas	NULL
were	NULL
collected	NULL
and	NULL
analyzed	NULL
separately	NULL
.	NULL

For	NULL
histological	NULL
examina-tion	NULL
,	NULL
fresh	NULL
pancreatic	NULL
tissue	NULL
was	NULL
fixed	NULL
in	NULL
10	NULL
%	NULL
zinc-buffered	NULL
formalin	NULL
,	NULL
embedded	NULL
in	NULL
paraffin	NULL
,	NULL
and	NULL
cut	NULL
into	NULL
3-	NULL
to	NULL
5-pm-thick	NULL
sections	NULL
.	NULL

For	NULL
immunostaining	NULL
,	NULL
2-	NULL
to	NULL
4-mm	NULL
pieces	NULL
of	NULL
pancreas	NULL
were	NULL
fixed	NULL
in	NULL
4	NULL
%	NULL
paraformaldehyde	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
at	NULL
4°C	NULL
for	NULL
2	NULL
h	NULL
and	NULL
dehydrated	NULL
in	NULL
an	NULL
increasing	NULL
gradient	NULL
of	NULL
sucrose	NULL
solutions	NULL
(	NULL
0.5	NULL
,	NULL
1	NULL
,	NULL
and	NULL
2.3	NULL
M	NULL
)	NULL
at	NULL
4°C	NULL
.	NULL

Next	NULL
,	NULL
the	NULL
tissue	NULL
was	NULL
frozen	NULL
in	NULL
Tissue-Tek	NULL
OCT	NULL
and	NULL
stored	NULL
at	NULL
-80°C	NULL
.	NULL

Immunohistochemistry	NULL
For	NULL
immunohistochemical	NULL
detection	NULL
of	NULL
neutrophils	NULL
,	NULL
8-um-thick	NULL
cryosections	NULL
were	NULL
mounted	NULL
on	NULL
poly-L-lysine-coated	NULL
glass	NULL
slides	NULL
.	NULL

After	NULL
being	NULL
washed	NULL
with	NULL
PBS	NULL
for	NULL
5	NULL
min	NULL
and	NULL
then	NULL
with	NULL
PBS	NULL
containing	NULL
0.05	NULL
M	NULL
glycine	NULL
(	NULL
PBS/glycine	NULL
)	NULL
for	NULL
10	NULL
min	NULL
,	NULL
sections	NULL
were	NULL
incubated	NULL
in	NULL
a	NULL
blocking	NULL
medium	NULL
containing	NULL
PBS/glycine	NULL
,	NULL
1	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
goat	NULL
serum	NULL
,	NULL
1	NULL
%	NULL
(	NULL
wt/vol	NULL
)	NULL
BSA	NULL
,	NULL
and	NULL
1	NULL
%	NULL
(	NULL
wt/vol	NULL
)	NULL
gelatin	NULL
.	NULL

After	NULL
20	NULL
min	NULL
,	NULL
tissue	NULL
sections	NULL
were	NULL
transferred	NULL
to	NULL
working	NULL
medium	NULL
(	NULL
PBS/glycine	NULL
,	NULL
0.1	NULL
%	NULL
goat	NULL
serum	NULL
,	NULL
0.1	NULL
%	NULL
BSA	NULL
,	NULL
and	NULL
0.1	NULL
%	NULL
gelatin	NULL
)	NULL
for	NULL
10	NULL
min	NULL
followed	NULL
by	NULL
a	NULL
2-h	NULL
incubation	NULL
with	NULL
rabbit	NULL
anti-rat	NULL
polymorphonuclear	NULL
leukocyte	NULL
antibody	NULL
conjugated	NULL
with	NULL
FITC	NULL
at	NULL
1:125	NULL
dilution	NULL
.	NULL

The	NULL
sections	NULL
were	NULL
then	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
PBS	NULL
and	NULL
air	NULL
dried	NULL
.	NULL

Anti-fading	NULL
mixture	NULL
(	NULL
4	NULL
%	NULL
propyl	NULL
gallate	NULL
and	NULL
90	NULL
%	NULL
glycerol	NULL
in	NULL
PBS	NULL
,	NULL
pH	NULL
7.8	NULL
)	NULL
was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
FITC-stained	NULL
neutrophils	NULL
were	NULL
imaged	NULL
by	NULL
fluorescence	NULL
microscopy	NULL
using	NULL
a	NULL
Nikon	NULL
Dia-phot	NULL
microscope	NULL
.	NULL

For	NULL
p65	NULL
immunolocalization	NULL
,	NULL
paraffin	NULL
sections	NULL
and	NULL
the	NULL
ABC	NULL
Peroxidase	NULL
Staining	NULL
Kit	NULL
were	NULL
used	NULL
.	NULL

Endogenous	NULL
peroxidase	NULL
activity	NULL
was	NULL
blocked	NULL
by	NULL
tissue	NULL
incubation	NULL
in	NULL
0.3	NULL
%	NULL
HO	NULL
in	NULL
methanol	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Slides	NULL
were	NULL
washed	NULL
with	NULL
PBS	NULL
for	NULL
5	NULL
min	NULL
and	NULL
then	NULL
with	NULL
PBS	NULL
containing	NULL
0.05	NULL
M	NULL
glycine	NULL
for	NULL
10	NULL
min	NULL
.	NULL

Sections	NULL
were	NULL
blocked	NULL
in	NULL
the	NULL
blocking	NULL
medium	NULL
for	NULL
20	NULL
min	NULL
,	NULL
washed	NULL
for	NULL
10	NULL
min	NULL
in	NULL
the	NULL
working	NULL
medium	NULL
,	NULL
and	NULL
incubated	NULL
overnight	NULL
at	NULL
4°C	NULL
with	NULL
anti-p65	NULL
antibody	NULL
at	NULL
1:50	NULL
dilution	NULL
.	NULL

Downloaded	NULL
from	NULL
www.physiclogy.org/journal/ajpgi	NULL
(	NULL
173.236.240.127	NULL
)	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

NF-KB	NULL
ACTIVATION	NULL
IN	NULL
TAUROCHOLATE	NULL
PANCREATITIS	NULL
Slides	NULL
were	NULL
then	NULL
washed	NULL
with	NULL
PBS	NULL
three	NULL
times	NULL
for	NULL
10	NULL
min	NULL
and	NULL
incubated	NULL
for	NULL
2	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
biotin-conjugated	NULL
secondary	NULL
antibody	NULL
diluted	NULL
in	NULL
the	NULL
working	NULL
buffer	NULL
(	NULL
1:200	NULL
)	NULL
.	NULL

Sections	NULL
were	NULL
washed	NULL
with	NULL
PBS/glycine	NULL
buffer	NULL
and	NULL
incubated	NULL
with	NULL
ABC	NULL
peroxidase	NULL
reagent	NULL
for	NULL
30	NULL
min	NULL
,	NULL
then	NULL
washed	NULL
with	NULL
PBS/glycine	NULL
buffer	NULL
three	NULL
times	NULL
for	NULL
10	NULL
min	NULL
,	NULL
incubated	NULL
with	NULL
diaminobenzidine	NULL
substrate	NULL
and	NULL
H2Osz	NULL
,	NULL
washed	NULL
in	NULL
PBS/glycine	NULL
buffer	NULL
three	NULL
times	NULL
for	NULL
10	NULL
min	NULL
,	NULL
and	NULL
examined	NULL
by	NULL
light	NULL
microscopy	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
p65	NULL
staining	NULL
was	NULL
confirmed	NULL
by	NULL
the	NULL
use	NULL
of	NULL
secondary	NULL
reagents	NULL
,	NULL
omitting	NULL
the	NULL
primary	NULL
antibody	NULL
.	NULL

Values	NULL
were	NULL
obtained	NULL
by	NULL
counting	NULL
the	NULL
number	NULL
of	NULL
neutrophils	NULL
(	NULL
or	NULL
the	NULL
number	NULL
of	NULL
acinar	NULL
cell	NULL
nuclei	NULL
immunoreactive	NULL
for	NULL
p65	NULL
)	NULL
per	NULL
100	NULL
acinar	NULL
cells	NULL
.	NULL

An	NULL
average	NULL
of	NULL
100	NULL
fields	NULL
was	NULL
counted	NULL
for	NULL
neutrophils	NULL
,	NULL
and	NULL
an	NULL
average	NULL
of	NULL
20	NULL
fields	NULL
was	NULL
counted	NULL
for	NULL
p65	NULL
immunolocalization	NULL
from	NULL
four	NULL
to	NULL
six	NULL
rats	NULL
for	NULL
each	NULL
condition	NULL
.	NULL

Assays	NULL
Measurement	NULL
of	NULL
active	NULL
trypsin	NULL
.	NULL

Trypsin	NULL
activity	NULL
in	NULL
pancreatic	NULL
tissue	NULL
homogenates	NULL
was	NULL
measured	NULL
by	NULL
a	NULL
fluorimetric	NULL
assay	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Kawabata	NULL
et	NULL
al	NULL
.	NULL

(	NULL
28	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
tissue	NULL
was	NULL
homogenized	NULL
on	NULL
ice	NULL
in	NULL
3	NULL
vol	NULL
of	NULL
a	NULL
buffer	NULL
containing	NULL
5	NULL
mM	NULL
MES	NULL
(	NULL
pH	NULL
6.5	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
MgSO	NULL
«	NULL
,	NULL
and	NULL
250	NULL
mM	NULL
sucrose	NULL
using	NULL
a	NULL
glass-Teflon	NULL
homogenizer	NULL
.	NULL

A	NULL
aliquot	NULL
of	NULL
the	NULL
homogenate	NULL
was	NULL
added	NULL
to	NULL
2	NULL
ml	NULL
of	NULL
the	NULL
assay	NULL
buffer	NULL
containing	NULL
50	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
CaC	NULL
)	NULL
ls	NULL
,	NULL
and	NULL
0.1	NULL
mg/ml	NULL
BSA	NULL
in	NULL
a	NULL
stirred	NULL
cuvette	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
started	NULL
by	NULL
adding	NULL
the	NULL
Boc-Glu-Ala-Arg-AMC	NULL
substrate	NULL
and	NULL
was	NULL
followed	NULL
for	NULL
5	NULL
min	NULL
.	NULL

The	NULL
increase	NULL
in	NULL
fluorescence	NULL
(	NULL
excita-tion	NULL
380	NULL
nm	NULL
,	NULL
emission	NULL
440	NULL
nm	NULL
)	NULL
was	NULL
linear	NULL
during	NULL
the	NULL
obser-vation	NULL
.	NULL

Trypsin	NULL
activity	NULL
in	NULL
the	NULL
homogenate	NULL
was	NULL
calculated	NULL
using	NULL
a	NULL
standard	NULL
curve	NULL
for	NULL
purified	NULL
trypsin	NULL
obtained	NULL
by	NULL
the	NULL
same	NULL
procedure	NULL
.	NULL

Preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
.	NULL

Nuclear	NULL
protein	NULL
extracts	NULL
from	NULL
pancreatic	NULL
tissue	NULL
were	NULL
prepared	NULL
for	NULL
gel	NULL
shift	NULL
assay	NULL
as	NULL
described	NULL
earlier	NULL
(	NULL
17	NULL
,	NULL
39	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
100-200	NULL
mg	NULL
of	NULL
frozen	NULL
tissue	NULL
were	NULL
powdered	NULL
in	NULL
a	NULL
mortar	NULL
in	NULL
liquid	NULL
nitrogen	NULL
and	NULL
lysed	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
a	NULL
low-salt	NULL
buffer	NULL
(	NULL
17	NULL
)	NULL
with	NULL
20	NULL
strokes	NULL
in	NULL
a	NULL
glass	NULL
Dounce	NULL
homogenizer	NULL
.	NULL

Before	NULL
use	NULL
,	NULL
the	NULL
lysis	NULL
buffer	NULL
was	NULL
supplemented	NULL
with	NULL
phenylmethylsulfony	NULL
]	NULL
l	NULL
fluoride	NULL
(	NULL
PMSF	NULL
)	NULL
and	NULL
di-thiothreitol	NULL
(	NULL
DTT	NULL
)	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
1	NULL
mM	NULL
each	NULL
and	NULL
with	NULL
the	NULL
protease-inhibitor	NULL
cocktail	NULL
containing	NULL
5	NULL
ug/ml	NULL
each	NULL
of	NULL
pepstatin	NULL
,	NULL
leupeptin	NULL
,	NULL
chymostatin	NULL
,	NULL
antipain	NULL
,	NULL
and	NULL
aprotinin	NULL
.	NULL

After	NULL
20	NULL
min	NULL
,	NULL
10	NULL
%	NULL
Igepal	NULL
CA-630	NULL
was	NULL
added	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
0.8	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
,	NULL
and	NULL
then	NULL
nuclei	NULL
were	NULL
collected	NULL
by	NULL
30	NULL
s	NULL
microcentrifugation	NULL
.	NULL

Nuclear	NULL
protein	NULL
was	NULL
extracted	NULL
from	NULL
pelleted	NULL
nuclei	NULL
in	NULL
a	NULL
high-salt	NULL
buffer	NULL
(	NULL
17	NULL
)	NULL
supplemented	NULL
with	NULL
1	NULL
mM	NULL
PMSF	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
and	NULL
the	NULL
protease	NULL
inhibitor	NULL
cocktail	NULL
described	NULL
previously	NULL
for	NULL
up	NULL
to	NULL
1	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

Nuclear	NULL
membranes	NULL
were	NULL
pelleted	NULL
by	NULL
microcentrifugation	NULL
for	NULL
10	NULL
min	NULL
,	NULL
and	NULL
the	NULL
clear	NULL
supernatant	NULL
(	NULL
nuclear	NULL
extract	NULL
)	NULL
was	NULL
separated	NULL
into	NULL
ali-quots	NULL
and	NULL
stored	NULL
at	NULL
-80°C	NULL
.	NULL

The	NULL
protein	NULL
content	NULL
of	NULL
the	NULL
nuclear	NULL
extract	NULL
was	NULL
determined	NULL
using	NULL
the	NULL
Bio-Rad	NULL
protein	NULL
assay	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
experiments	NULL
were	NULL
performed	NULL
using	NULL
double-stranded	NULL
oligonucleotides	NULL
comprising	NULL
the	NULL
consensus	NULL
sequences	NULL
(	NULL
underlined	NULL
)	NULL
for	NULL
NF-kB	NULL
(	NULL
5'-GCAGAGGGGACTT-TCCGAGA	NULL
)	NULL
and	NULL
AP-1	NULL
(	NULL
5'-GGCTTGATGAGTCAGCCGGAA	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
site	NULL
for	NULL
AP-1	NULL
comprised	NULL
the	NULL
phorbol	NULL
ester-re-sponsive	NULL
element	NULL
.	NULL

Oligonucleotides	NULL
were	NULL
end	NULL
labeled	NULL
with	NULL
[	NULL
P°P	NULL
]	NULL
dCTP	NULL
using	NULL
Klenow	NULL
DNA	NULL
polymerase	NULL
I	NULL
.	NULL

In	NULL
the	NULL
mutated	NULL
NF-xB	NULL
oligonucleotide	NULL
,	NULL
the	NULL
xB	NULL
motif	NULL
was	NULL
changed	NULL
to	NULL
GGeceAC-TaaCC	NULL
.	NULL

Nuclear	NULL
proteins	NULL
(	NULL
7-10	NULL
ug	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
°°P-labeled	NULL
oligonucleotide	NULL
probe	NULL
under	NULL
binding	NULL
conditions	NULL
[	NULL
10	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.8	NULL
)	NULL
,	NULL
50	NULL
mM	NULL
KCl	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
G1199	NULL
DTT	NULL
,	NULL
10	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
glycerol	NULL
,	NULL
and	NULL
3	NULL
ug	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
]	NULL
for	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
20	NULL
pl	NULL
.	NULL

For	NULL
cold	NULL
competition	NULL
,	NULL
a	NULL
100X	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
wild-type	NULL
or	NULL
mutated	NULL
oligonucleotides	NULL
was	NULL
added	NULL
with	NULL
the	NULL
probe	NULL
.	NULL

For	NULL
supershift	NULL
experiments	NULL
,	NULL
2-4	NULL
pg	NULL
of	NULL
specific	NULL
antibodies	NULL
against	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
p65	NULL
(	NULL
Rel	NULL
A	NULL
)	NULL
,	NULL
p50	NULL
,	NULL
p52	NULL
,	NULL
and	NULL
c-Rel	NULL
or	NULL
against	NULL
AP-1	NULL
proteins	NULL
c-Fos	NULL
,	NULL
c-Jun	NULL
,	NULL
Jun-B	NULL
,	NULL
Jun-D	NULL
,	NULL
and	NULL
Fra-2	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
binding	NULL
reaction	NULL
mixture	NULL
for	NULL
40	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
before	NULL
addition	NULL
of	NULL
the	NULL
probe	NULL
.	NULL

After	NULL
binding	NULL
,	NULL
protein-DNA	NULL
complexes	NULL
were	NULL
electrophoresed	NULL
on	NULL
a	NULL
native	NULL
4.5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
at	NULL
200	NULL
volts	NULL
using	NULL
0.5	NULL
%	NULL
TBE	NULL
buffer	NULL
(	NULL
1xx	NULL
TBE	NULL
:	NULL
89	NULL
mM	NULL
Tris	NULL
base	NULL
,	NULL
89	NULL
mM	NULL
boric	NULL
acid	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
EDTA	NULL
)	NULL
.	NULL

After	NULL
being	NULL
dried	NULL
,	NULL
the	NULL
gels	NULL
were	NULL
quantified	NULL
in	NULL
the	NULL
PhosphorImager	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
,	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Semiquantitative	NULL
RT-PCR	NULL
analysis	NULL
of	NULL
mRNA	NULL
expression	NULL
.	NULL

The	NULL
procedure	NULL
for	NULL
semiquantitative	NULL
RT-PCR	NULL
was	NULL
essentially	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
17	NULL
,	NULL
39	NULL
)	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
pancreatic	NULL
tissue	NULL
using	NULL
the	NULL
TRIzol	NULL
reagent	NULL
.	NULL

RNA	NULL
quality	NULL
was	NULL
verified	NULL
by	NULL
ethidium	NULL
bromide	NULL
staining	NULL
of	NULL
ribosomal	NULL
RNA	NULL
bands	NULL
on	NULL
denaturing	NULL
agarose	NULL
gel	NULL
.	NULL

Total	NULL
RNA	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
was	NULL
reverse-transcribed	NULL
using	NULL
oligo	NULL
(	NULL
dT	NULL
)	NULL
as	NULL
a	NULL
primer	NULL
(	NULL
SuperScript	NULL
II	NULL
Preamplification	NULL
System	NULL
)	NULL
.	NULL

cDNA	NULL
obtained	NULL
from	NULL
0.5	NULL
ug	NULL
total	NULL
RNA	NULL
was	NULL
subjected	NULL
to	NULL
PCR	NULL
using	NULL
rat	NULL
gene-specific	NULL
primers	NULL
for	NULL
IL-6	NULL
,	NULL
TNF-	NULL
«	NULL
,	NULL
KC	NULL
,	NULL
MCP-1	NULL
,	NULL
and	NULL
iNOS	NULL
.	NULL

The	NULL
primer	NULL
sequences	NULL
were	NULL
described	NULL
previously	NULL
(	NULL
17	NULL
,	NULL
39	NULL
)	NULL
.	NULL

Amplification	NULL
was	NULL
for	NULL
a	NULL
different	NULL
number	NULL
of	NULL
cycles	NULL
(	NULL
between	NULL
22	NULL
and	NULL
32	NULL
)	NULL
to	NULL
yield	NULL
visible	NULL
products	NULL
within	NULL
the	NULL
linear	NULL
amplification	NULL
range	NULL
.	NULL

For	NULL
a	NULL
given	NULL
target	NULL
sequence	NULL
,	NULL
the	NULL
same	NULL
cycle	NULL
number	NULL
was	NULL
applied	NULL
for	NULL
cDNAs	NULL
from	NULL
all	NULL
animals	NULL
studied	NULL
.	NULL

Negative	NULL
controls	NULL
were	NULL
performed	NULL
by	NULL
omitting	NULL
the	NULL
RT	NULL
step	NULL
or	NULL
the	NULL
cDNA	NULL
template	NULL
from	NULL
PCR	NULL
amplification	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
the	NULL
RT-PCR	NULL
products	NULL
was	NULL
confirmed	NULL
by	NULL
direct	NULL
sequencing	NULL
.	NULL

They	NULL
were	NULL
separated	NULL
on	NULL
an	NULL
agarose	NULL
gel	NULL
containing	NULL
ethidium	NULL
bromide	NULL
,	NULL
photographed	NULL
,	NULL
and	NULL
quantified	NULL
using	NULL
an	NULL
AMBIS	NULL
image	NULL
analysis	NULL
system	NULL
(	NULL
Scanalytics	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Background	NULL
correction	NULL
in	NULL
the	NULL
densitometry	NULL
was	NULL
performed	NULL
using	NULL
an	NULL
area	NULL
immediately	NULL
adjacent	NULL
to	NULL
the	NULL
RT-PCR	NULL
product	NULL
band	NULL
.	NULL

mRNA	NULL
levels	NULL
were	NULL
normalized	NULL
to	NULL
the	NULL
density	NULL
of	NULL
the	NULL
RT-PCR	NULL
product	NULL
for	NULL
acidic	NULL
ribosomal	NULL
phosphoprotein	NULL
PO	NULL
(	NULL
ARP	NULL
)	NULL
,	NULL
used	NULL
as	NULL
a	NULL
housekeeping	NULL
gene	NULL
,	NULL
in	NULL
the	NULL
same	NULL
sample	NULL
,	NULL
as	NULL
we	NULL
described	NULL
previously	NULL
(	NULL
17	NULL
,	NULL
89	NULL
)	NULL
.	NULL

Statistical	NULL
Analysis	NULL
Data	NULL
are	NULL
presented	NULL
as	NULL
means	NULL
+	NULL
SE	NULL
of	NULL
the	NULL
values	NULL
.	NULL

Statistical	NULL
differences	NULL
between	NULL
values	NULL
from	NULL
two	NULL
groups	NULL
were	NULL
determined	NULL
by	NULL
the	NULL
unpaired	NULL
Student	NULL
's	NULL
é-test	NULL
.	NULL

For	NULL
normally	NULL
distributed	NULL
parameters	NULL
,	NULL
differences	NULL
between	NULL
more	NULL
than	NULL
two	NULL
groups	NULL
were	NULL
determined	NULL
by	NULL
one-way	NULL
ANOVA	NULL
,	NULL
and	NULL
multiple	NULL
comparisons	NULL
were	NULL
performed	NULL
by	NULL
using	NULL
Newman-Keuls	NULL
post	NULL
hoc	NULL
analysis	NULL
.	NULL

For	NULL
parameters	NULL
without	NULL
normal	NULL
distribution	NULL
,	NULL
differences	NULL
between	NULL
more	NULL
than	NULL
two	NULL
groups	NULL
were	NULL
determined	NULL
by	NULL
the	NULL
Kruskal-Wallis	NULL
test	NULL
and	NULL
Dunn	NULL
's	NULL
post	NULL
hoe	NULL
analysis	NULL
.	NULL

A	NULL
P	NULL
value	NULL
<	NULL
0.05	NULL
was	NULL
considered	NULL
statistically	NULL
significant	NULL
.	NULL

RESULTS	NULL
Macroscopic	NULL
and	NULL
Histological	NULL
Examination	NULL
of	NULL
the	NULL
Pancreas	NULL
Rats	NULL
that	NULL
received	NULL
intraductal	NULL
infusion	NULL
of	NULL
saline	NULL
showed	NULL
slight	NULL
pancreatic	NULL
edema	NULL
,	NULL
and	NULL
light	NULL
microscopy	NULL
revealed	NULL
a	NULL
mild	NULL
degree	NULL
of	NULL
interstitial	NULL
edema	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
after	NULL
1	NULL
or	NULL
6	NULL
h	NULL
of	NULL
taurocholate	NULL
infusion	NULL
,	NULL
all	NULL
of	NULL
the	NULL
animals	NULL
had	NULL
severe	NULL
necrohemorrhagic	NULL
pancreatitis	NULL
,	NULL
observed	NULL
grossly	NULL
and	NULL
by	NULL
light	NULL
microscopy	NULL
,	NULL
that	NULL
mostly	NULL
affected	NULL
the	NULL
head	NULL
segment	NULL
of	NULL
the	NULL
pancreas	NULL
.	NULL

The	NULL
pancreatic	NULL
tail	NULL
had	NULL
normal	NULL
histology	NULL
in	NULL
most	NULL
of	NULL
the	NULL
animals	NULL
.	NULL

Downloaded	NULL
from	NULL
www.physiclogy.org/journal/ajpgi	NULL
(	NULL
173.236.240.127	NULL
)	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

G1200	NULL
A	NULL
B	NULL
amylase	NULL
,	NULL
U/ml	NULL
CJ	NULL
lipase	NULL
,	NULL
U/ml	NULL
Saline	NULL
-	NULL
+	NULL
-	NULL
+	NULL
TC	NULL
-	NULL
-	NULL
+	NULL
-	NULL
0+	NULL
ou	NULL
oke	NULL
og	NULL
control	NULL
_	NULL
1	NULL
hour	NULL
6	NULL
hours	NULL
control	NULL
22	NULL
222g	NULL
g	NULL
1	NULL
hour	NULL
NF-KB	NULL
ACTIVATION	NULL
IN	NULL
TAUROCHOLATE	NULL
PANCREATITIS	NULL
=15	NULL
x	NULL
g	NULL
=	NULL
S	NULL
€	NULL
&	NULL
10	NULL
=	NULL
o	NULL
.	NULL

0	NULL
§	NULL
s	NULL
F	NULL
#	NULL
C	NULL
xt	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
6	NULL
hours	NULL
control	NULL
-	NULL
1	NULL
hour	NULL
6	NULL
hours	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Serum	NULL
amylase	NULL
(	NULL
A	NULL
)	NULL
and	NULL
lipase	NULL
(	NULL
B	NULL
)	NULL
and	NULL
neutrophil	NULL
infiltration	NULL
(	NULL
C	NULL
)	NULL
in	NULL
the	NULL
pancreatic	NULL
head	NULL
in	NULL
taurocholate-induced	NULL
pancreatitis	NULL
.	NULL

Animals	NULL
were	NULL
either	NULL
killed	NULL
without	NULL
any	NULL
treatment	NULL
(	NULL
control	NULL
)	NULL
or	NULL
at	NULL
1	NULL
or	NULL
6	NULL
h	NULL
after	NULL
receiving	NULL
intraductal	NULL
infusion	NULL
of	NULL
either	NULL
saline	NULL
or	NULL
taurocholate	NULL
(	NULL
TC	NULL
)	NULL
.	NULL

Values	NULL
are	NULL
means	NULL
*	NULL
SE	NULL
for	NULL
at	NULL
least	NULL
4	NULL
animals	NULL
in	NULL
each	NULL
group	NULL
.	NULL

*Values	NULL
are	NULL
significantly	NULL
greater	NULL
(	NULL
P	NULL
<	NULL
0.05	NULL
)	NULL
than	NULL
for	NULL
all	NULL
other	NULL
conditions	NULL
.	NULL

vValues	NULL
are	NULL
significantly	NULL
greater	NULL
(	NULL
P	NULL
<	NULL
0.05	NULL
)	NULL
than	NULL
for	NULL
control	NULL
when	NULL
taurocholate	NULL
and	NULL
control	NULL
groups	NULL
are	NULL
compared	NULL
.	NULL

#	NULL
Values	NULL
are	NULL
significantly	NULL
greater	NULL
(	NULL
P	NULL
<	NULL
0.05	NULL
)	NULL
than	NULL
for	NULL
control	NULL
when	NULL
saline	NULL
and	NULL
control	NULL
groups	NULL
are	NULL
compared	NULL
.	NULL

Parameters	NULL
of	NULL
Pancreatitis	NULL
:	NULL
Serum	NULL
Amylase	NULL
and	NULL
Lipase	NULL
,	NULL
Pancreatic	NULL
Neutrophil	NULL
Infiltration	NULL
,	NULL
and	NULL
Trypsin	NULL
Activation	NULL
Figure	NULL
1	NULL
shows	NULL
the	NULL
levels	NULL
of	NULL
serum	NULL
amylase	NULL
and	NULL
lipase	NULL
and	NULL
the	NULL
infiltration	NULL
of	NULL
neutrophils	NULL
in	NULL
pancreatic	NULL
tissue	NULL
in	NULL
untreated	NULL
rats	NULL
and	NULL
in	NULL
those	NULL
at	NULL
1	NULL
or	NULL
6	NULL
h	NULL
after	NULL
receiving	NULL
intraductal	NULL
infusion	NULL
of	NULL
either	NULL
saline	NULL
or	NULL
taurocholate	NULL
.	NULL

Animals	NULL
infused	NULL
with	NULL
taurocholate	NULL
showed	NULL
a	NULL
time-dependent	NULL
increase	NULL
of	NULL
serum	NULL
amylase	NULL
and	NULL
lipase	NULL
that	NULL
was	NULL
already	NULL
significant	NULL
after	NULL
1	NULL
h	NULL
of	NULL
the	NULL
infusion	NULL
.	NULL

Intraductal	NULL
saline	NULL
infusion	NULL
induced	NULL
a	NULL
smaller	NULL
increase	NULL
in	NULL
serum	NULL
amylase	NULL
and	NULL
lipase	NULL
that	NULL
was	NULL
significantly	NULL
higher	NULL
compared	NULL
with	NULL
the	NULL
control	NULL
group	NULL
.	NULL

The	NULL
number	NULL
of	NULL
infiltrating	NULL
neutrophils	NULL
in	NULL
the	NULL
pancreatic	NULL
head	NULL
of	NULL
taurocholate-infused	NULL
rats	NULL
followed	NULL
a	NULL
similar	NULL
time-dependent	NULL
pattern	NULL
as	NULL
the	NULL
amylase	NULL
and	NULL
lipase	NULL
levels	NULL
.	NULL

The	NULL
number	NULL
of	NULL
neutrophils	NULL
in	NULL
the	NULL
pancreatic	NULL
head	NULL
increased	NULL
also	NULL
in	NULL
the	NULL
6-h	NULL
saline	NULL
group	NULL
,	NULL
but	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
.	NULL

In	NULL
control	NULL
pancreata	NULL
,	NULL
no	NULL
inflammatory	NULL
infiltration	NULL
was	NULL
seen	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

Trypsin	NULL
activation	NULL
was	NULL
also	NULL
evaluated	NULL
separately	NULL
in	NULL
the	NULL
pancreatic	NULL
head	NULL
and	NULL
tail	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

In	NULL
the	NULL
head	NULL
of	NULL
the	NULL
pancreas	NULL
,	NULL
trypsin	NULL
activity	NULL
increased	NULL
at	NULL
1	NULL
h	NULL
and	NULL
then	NULL
further	NULL
at	NULL
6	NULL
h	NULL
after	NULL
taurocholate	NULL
infusion	NULL
.	NULL

The	NULL
saline	NULL
treatment	NULL
induced	NULL
a	NULL
smaller	NULL
increase	NULL
that	NULL
was	NULL
statistically	NULL
significant	NULL
in	NULL
the	NULL
6-h	NULL
saline	NULL
group	NULL
compared	NULL
with	NULL
control	NULL
and	NULL
1-h	NULL
saline	NULL
groups	NULL
.	NULL

Trypsin	NULL
activity	NULL
in	NULL
the	NULL
pancreatic	NULL
tail	NULL
after	NULL
taurocholate	NULL
infusion	NULL
showed	NULL
a	NULL
much	NULL
smaller	NULL
increase	NULL
than	NULL
in	NULL
the	NULL
head	NULL
(	NULL
P	NULL
<	NULL
0.05	NULL
)	NULL
and	NULL
was	NULL
not	NULL
statistically	NULL
different	NULL
from	NULL
the	NULL
control	NULL
group	NULL
.	NULL

Activation	NULL
of	NULL
Pancreatic	NULL
NF-kB	NULL
in	NULL
Taurocholate-Induced	NULL
Pancreatitis	NULL
In	NULL
the	NULL
pancreas	NULL
of	NULL
normal	NULL
rats	NULL
,	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
was	NULL
virtually	NULL
undetectable	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
taurocholate	NULL
infusion	NULL
caused	NULL
a	NULL
time-dependent	NULL
NF-	NULL
<	NULL
B	NULL
activation	NULL
in	NULL
the	NULL
pancreatic	NULL
head	NULL
.	NULL

The	NULL
course	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
paralleled	NULL
that	NULL
of	NULL
serum	NULL
amylase	NULL
and	NULL
lipase	NULL
levels	NULL
and	NULL
neutrophil	NULL
infiltration	NULL
,	NULL
with	NULL
the	NULL
highest	NULL
increase	NULL
(	NULL
5-fold	NULL
over	NULL
the	NULL
control	NULL
group	NULL
)	NULL
detected	NULL
6	NULL
h	NULL
after	NULL
the	NULL
taurocholate	NULL
infusion	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Saline	NULL
infu-	NULL
sion	NULL
caused	NULL
minor	NULL
NF-	NULL
<	NULL
B	NULL
activation	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
was	NULL
demonstrated	NULL
by	NULL
cold	NULL
competition	NULL
experiments	NULL
using	NULL
wild-type	NULL
and	NULL
mutated	NULL
B	NULL
oligonucleotides	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

Only	NULL
wild-type	NULL
,	NULL
and	NULL
not	NULL
mu-tated	NULL
,	NULL
xB	NULL
oligonucleotide	NULL
competed	NULL
with	NULL
the	NULL
probe	NULL
for	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
.	NULL

Composition	NULL
of	NULL
NF-kB	NULL
Complexes	NULL
NF-KB	NULL
exists	NULL
as	NULL
homo-	NULL
or	NULL
heterodimer	NULL
composed	NULL
of	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

l	NULL
protein	NULL
family	NULL
.	NULL

To	NULL
characterize	NULL
complexes	NULL
activated	NULL
in	NULL
taurocholate	NULL
pancreatitis	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
pancreatic	NULL
head	NULL
of	NULL
6-h	NULL
taurocholate-infused	NULL
animals	NULL
were	NULL
analyzed	NULL
in	NULL
supershift	NULL
experiments	NULL
using	NULL
antibodies	NULL
against	NULL
p65	NULL
(	NULL
Rel	NULL
A	NULL
)	NULL
,	NULL
p50	NULL
,	NULL
p52	NULL
,	NULL
or	NULL
c-Rel	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
antibody	NULL
against	NULL
p65	NULL
decreased	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
NF-	NULL
<	NULL
B-specific	NULL
band	NULL
,	NULL
and	NULL
the	NULL
antibody	NULL
against	NULL
p50	NULL
produced	NULL
a	NULL
Pancreatic	NULL
head	NULL
Pancreatic	NULL
tail	NULL
trypsin	NULL
activity	NULL
(	NULL
pmol/mg	NULL
protein	NULL
)	NULL
Saline	NULL
-	NULL
+	NULL
=	NULL
+	NULL
=	NULL
+	NULL
TCG	NULL
-	NULL
-	NULL
#	NULL
-	NULL
+	NULL
#	NULL
-o	NULL
+	NULL
_i	NULL
control	NULL
1	NULL
hour	NULL
6	NULL
hours	NULL
6	NULL
hours	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Trypsin	NULL
activity	NULL
in	NULL
the	NULL
pancreatic	NULL
head	NULL
and	NULL
tail	NULL
from	NULL
control	NULL
rats	NULL
and	NULL
from	NULL
rats	NULL
1	NULL
or	NULL
6	NULL
h	NULL
after	NULL
intraductal	NULL
infusion	NULL
of	NULL
either	NULL
saline	NULL
or	NULL
taurocholate	NULL
.	NULL

Values	NULL
are	NULL
means	NULL
+	NULL
SE	NULL
for	NULL
at	NULL
least	NULL
5	NULL
animals	NULL
in	NULL
each	NULL
group	NULL
.	NULL

*Values	NULL
are	NULL
significantly	NULL
greater	NULL
(	NULL
P	NULL
<	NULL
0.05	NULL
)	NULL
than	NULL
those	NULL
for	NULL
all	NULL
other	NULL
conditions	NULL
.	NULL

#	NULL
Values	NULL
are	NULL
significantly	NULL
greater	NULL
(	NULL
P	NULL
<	NULL
0.05	NULL
)	NULL
than	NULL
for	NULL
control	NULL
when	NULL
saline	NULL
and	NULL
control	NULL
groups	NULL
are	NULL
compared	NULL
.	NULL

**Values	NULL
are	NULL
significantly	NULL
different	NULL
(	NULL
P	NULL
<	NULL
0.05	NULL
)	NULL
between	NULL
pancreatic	NULL
head	NULL
and	NULL
the	NULL
corresponding	NULL
tail	NULL
.	NULL

Downloaded	NULL
from	NULL
www.physiclogy.org/journal/ajpgi	NULL
(	NULL
173.236.240.127	NULL
)	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

NF-KB	NULL
ACTIVATION	NULL
IN	NULL
TAUROCHOLATE	NULL
PANCREATITIS	NULL
1	NULL
hour	NULL
6	NULL
hours	NULL
Cont	NULL
Saline	NULL
TC	NULL
Saline	NULL
TC	NULL
-or	NULL
NEE	NULL
wuuuuuuuwuuu	NULL
G1201	NULL
*	NULL
c	NULL
2	NULL
ESI	NULL
S	NULL
3	NULL
5	NULL
0	NULL
©	NULL
x*	NULL
2	NULL
1	NULL
Saline	NULL
=	NULL
+	NULL
=	NULL
+	NULL
=	NULL
TC	NULL
=	NULL
=	NULL
+	NULL
=	NULL
+	NULL
P	NULL
L______j	NULL
control	NULL
_	NULL
1	NULL
hour	NULL
6	NULL
hours	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Nuclear	NULL
factor-	NULL
«	NULL
xB	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
activation	NULL
in	NULL
pancreatic	NULL
head	NULL
of	NULL
rats	NULL
from	NULL
control	NULL
,	NULL
saline	NULL
,	NULL
and	NULL
taurocholate	NULL
groups	NULL
at	NULL
1	NULL
and	NULL
6	NULL
h	NULL
after	NULL
the	NULL
intraductal	NULL
infusion	NULL
.	NULL

Nuclear	NULL
protein	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
pancreatic	NULL
tissue	NULL
and	NULL
subjected	NULL
to	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
for	NULL
NF-xB	NULL
as	NULL
described	NULL
in	NULL
MATERIALS	NULL
AND	NULL
METHODS	NULL
.	NULL

A	NULL
:	NULL
representative	NULL
EMSA	NULL
for	NULL
pancreatic	NULL
NF-kB	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

B	NULL
:	NULL
levels	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

The	NULL
intensities	NULL
of	NULL
NF-kB	NULL
bands	NULL
were	NULL
quantified	NULL
in	NULL
the	NULL
PhosphorImager	NULL
and	NULL
are	NULL
shown	NULL
for	NULL
each	NULL
group	NULL
as	NULL
means	NULL
+	NULL
SE	NULL
relative	NULL
to	NULL
control	NULL
;	NULL
n	NULL
=	NULL
3-6	NULL
animals/group	NULL
.	NULL

*Values	NULL
are	NULL
significantly	NULL
greater	NULL
(	NULL
P	NULL
<	NULL
0.05	NULL
)	NULL
than	NULL
those	NULL
for	NULL
all	NULL
other	NULL
conditions	NULL
.	NULL

clear	NULL
supershift	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
p52	NULL
or	NULL
of	NULL
c-Rel	NULL
was	NULL
not	NULL
detected	NULL
by	NULL
the	NULL
supershift	NULL
assay	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
p65	NULL
and	NULL
p50	NULL
proteins	NULL
are	NULL
present	NULL
in	NULL
the	NULL
NF-	NULL
«	NULL
kB	NULL
complexes	NULL
activated	NULL
in	NULL
taurocholate	NULL
pancreatitis	NULL
.	NULL

To	NULL
further	NULL
analyze	NULL
cellular	NULL
localization	NULL
of	NULL
the	NULL
activated	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
we	NULL
performed	NULL
immunostaining	NULL
in	NULL
pancreatic	NULL
tissue	NULL
with	NULL
a	NULL
specific	NULL
antibody	NULL
to	NULL
p65	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
is	NULL
A	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Subunit	NULL
composition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
in	NULL
pancreatic	NULL
head	NULL
of	NULL
rats	NULL
from	NULL
the	NULL
6-h	NULL
taurocholate	NULL
group	NULL
.	NULL

A	NULL
:	NULL
cold	NULL
competition	NULL
experiments	NULL
confirming	NULL
the	NULL
specificity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
by	NULL
adding	NULL
100	NULL
%	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
wild-type	NULL
(	NULL
cold	NULL
wt	NULL
)	NULL
or	NULL
mutated	NULL
(	NULL
cold	NULL
mut	NULL
)	NULL
kB	NULL
oligonucleotide	NULL
.	NULL

B	NULL
:	NULL
supershift	NULL
analysis	NULL
using	NULL
antibodies	NULL
to	NULL
indicated	NULL
NF-kB	NULL
proteins	NULL
.	NULL

Arrow	NULL
shows	NULL
the	NULL
position	NULL
of	NULL
supershifted	NULL
band	NULL
.	NULL

Data	NULL
are	NULL
representative	NULL
of	NULL
2	NULL
animals	NULL
.	NULL

kept	NULL
in	NULL
inactive	NULL
form	NULL
in	NULL
the	NULL
cytoplasm	NULL
and	NULL
translocates	NULL
to	NULL
the	NULL
nucleus	NULL
upon	NULL
activation	NULL
.	NULL

Thus	NULL
immunostained	NULL
nuclei	NULL
indicate	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
activated	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

In	NULL
accordance	NULL
with	NULL
EMSA	NULL
data	NULL
,	NULL
p65	NULL
immunoreactivity	NULL
in	NULL
the	NULL
cell	NULL
nuclei	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
control	NULL
pancreas	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
pancreatic	NULL
tissue	NULL
from	NULL
the	NULL
6-h	NULL
taurocholate	NULL
group	NULL
,	NULL
in	NULL
which	NULL
a	NULL
strong	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
was	NULL
detected	NULL
by	NULL
EMSA	NULL
,	NULL
displayed	NULL
immunostained	NULL
nu-clei	NULL
,	NULL
confirming	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

In	NULL
both	NULL
control	NULL
and	NULL
pancreatitis	NULL
tissue	NULL
,	NULL
no	NULL
staining	NULL
was	NULL
observed	NULL
without	NULL
primary	NULL
antibody	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Most	NULL
of	NULL
immunoreactivity	NULL
was	NULL
confined	NULL
to	NULL
the	NULL
acinar	NULL
cell	NULL
population	NULL
,	NULL
and	NULL
~10	NULL
%	NULL
of	NULL
the	NULL
acinar	NULL
cell	NULL
nuclei	NULL
stained	NULL
for	NULL
p65	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

A	NULL
small	NULL
portion	NULL
of	NULL
infiltrated	NULL
neutrophils	NULL
also	NULL
showed	NULL
nuclear	NULL
p65	NULL
localization	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
Pancreatic	NULL
AP-1	NULL
Complexes	NULL
in	NULL
Taurocholate-Induced	NULL
Pancreatitis	NULL
In	NULL
the	NULL
pancreas	NULL
of	NULL
normal	NULL
rats	NULL
,	NULL
there	NULL
was	NULL
essentially	NULL
no	NULL
AP-1	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
AP-1	NULL
was	NULL
strongly	NULL
activated	NULL
in	NULL
pancreata	NULL
from	NULL
rats	NULL
at	NULL
1	NULL
and	NULL
6	NULL
h	NULL
after	NULL
infusion	NULL
of	NULL
either	NULL
saline	NULL
or	NULL
taurocholate	NULL
.	NULL

Thus	NULL
,	NULL
compared	NULL
with	NULL
NF-kB	NULL
,	NULL
pancreatic	NULL
AP-1	NULL
activation	NULL
developed	NULL
faster	NULL
.	NULL

Also	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
AP-1	NULL
binding	NULL
activity	NULL
in	NULL
both	NULL
saline-	NULL
and	NULL
taurocholate-infused	NULL
animals	NULL
was	NULL
stronger	NULL
than	NULL
that	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
AP-1	NULL
binding	NULL
was	NULL
confirmed	NULL
in	NULL
cold	NULL
competition	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
using	NULL
unlabeled	NULL
wild-type	NULL
or	NULL
unrelated	NULL
(	NULL
Oct-1	NULL
)	NULL
oligonucleotide	NULL
.	NULL

Downloaded	NULL
from	NULL
www.physiclogy.org/journal/ajpgi	NULL
(	NULL
173.236.240.127	NULL
)	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

G1202	NULL
A	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Immunohistochemistry	NULL
of	NULL
pancreatic	NULL
head	NULL
tissue	NULL
sections	NULL
from	NULL
control	NULL
group	NULL
(	NULL
A	NULL
)	NULL
and	NULL
6-h	NULL
taurocholate	NULL
group	NULL
(	NULL
B	NULL
and	NULL
C	NULL
)	NULL
stained	NULL
with	NULL
an	NULL
antibody	NULL
against	NULL
p65	NULL
.	NULL

In	NULL
B	NULL
,	NULL
arrowheads	NULL
indicate	NULL
acinar	NULL
cell	NULL
nuclei	NULL
positively	NULL
stained	NULL
for	NULL
p65	NULL
(	NULL
activated	NULL
NF-kB	NULL
)	NULL
;	NULL
arrows	NULL
point	NULL
to	NULL
the	NULL
acinar	NULL
cell	NULL
nuclei	NULL
not	NULL
stained	NULL
for	NULL
p65	NULL
.	NULL

In	NULL
C	NULL
,	NULL
double	NULL
arrowhead	NULL
indicates	NULL
a	NULL
leukocyte	NULL
positively	NULL
stained	NULL
for	NULL
nuclear	NULL
p65	NULL
;	NULL
double	NULL
arrow	NULL
points	NULL
to	NULL
a	NULL
leukocyte	NULL
not	NULL
stained	NULL
for	NULL
nuclear	NULL
p65	NULL
.	NULL

AP-1	NULL
is	NULL
a	NULL
dimeric	NULL
transcription	NULL
factor	NULL
that	NULL
consists	NULL
of	NULL
homodimers	NULL
of	NULL
the	NULL
Jun	NULL
family	NULL
proteins	NULL
(	NULL
c-Jun	NULL
,	NULL
Jun-B	NULL
,	NULL
and	NULL
Jun-D	NULL
)	NULL
or	NULL
Jun/Fos	NULL
heterodimers	NULL
.	NULL

Members	NULL
of	NULL
the	NULL
Fos	NULL
family	NULL
(	NULL
c-Fos	NULL
,	NULL
Fos-B	NULL
,	NULL
Fra-1	NULL
,	NULL
and	NULL
Fra-2	NULL
)	NULL
can	NULL
associate	NULL
with	NULL
different	NULL
Jun	NULL
proteins	NULL
to	NULL
form	NULL
the	NULL
heterodimeric	NULL
AP-1	NULL
complexes	NULL
.	NULL

The	NULL
composition	NULL
of	NULL
AP-1	NULL
complexes	NULL
in	NULL
pancreata	NULL
of	NULL
taurocholate-infused	NULL
animals	NULL
was	NULL
determined	NULL
by	NULL
supershift	NULL
analysis	NULL
using	NULL
antibodies	NULL
against	NULL
Jun	NULL
or	NULL
Fos	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

A	NULL
supershifted	NULL
band	NULL
was	NULL
detected	NULL
with	NULL
c-Fos	NULL
,	NULL
Jun-B	NULL
,	NULL
and	NULL
Fra-2	NULL
antibodies	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
Jun-B	NULL
antibody	NULL
also	NULL
caused	NULL
a	NULL
significant	NULL
decrease	NULL
of	NULL
the	NULL
specific	NULL
AP-1	NULL
band	NULL
(	NULL
Fig	NULL
.	NULL

A	NULL
1	NULL
hour	NULL
6	NULL
hours	NULL
Cont	NULL
Saline	NULL
TC	NULL
Saline	NULL
TC	NULL
``	NULL
H	NULL
“	NULL
H	NULL
“	NULL
W~	NULL
'	NULL
l	NULL
NS	NULL
h	NULL
dl	NULL
ld	NULL
Adal	NULL
A	NULL
0b	NULL
d	NULL
db	NULL
A	NULL
dl	NULL
uly	NULL
NF-KB	NULL
ACTIVATION	NULL
IN	NULL
TAUROCHOLATE	NULL
PANCREATITIS	NULL
B	NULL
C	NULL
7B	NULL
)	NULL
.	NULL

c-Jun	NULL
,	NULL
Jun-D	NULL
,	NULL
and	NULL
Fos-B	NULL
did	NULL
not	NULL
demonstrate	NULL
a	NULL
clear	NULL
supershift	NULL
or	NULL
intensity	NULL
decrease	NULL
of	NULL
the	NULL
AP-1	NULL
band	NULL
.	NULL

Thus	NULL
the	NULL
results	NULL
obtained	NULL
indicate	NULL
the	NULL
presence	NULL
of	NULL
c-Fos	NULL
,	NULL
Jun-B	NULL
,	NULL
and	NULL
Fra-2	NULL
in	NULL
AP-1	NULL
complex	NULL
(	NULL
es	NULL
)	NULL
activated	NULL
in	NULL
the	NULL
pancreas	NULL
of	NULL
taurocholate-infused	NULL
rats	NULL
.	NULL

Cytokine	NULL
,	NULL
Chemokine	NULL
,	NULL
and	NULL
iNOS	NULL
mRNA	NULL
Expression	NULL
in	NULL
Pancreatic	NULL
Tissue	NULL
To	NULL
determine	NULL
whether	NULL
there	NULL
is	NULL
upregulation	NULL
of	NULL
gene	NULL
expression	NULL
for	NULL
inflammatory	NULL
molecules	NULL
in	NULL
the	NULL
pancreas	NULL
,	NULL
mRNA	NULL
levels	NULL
of	NULL
the	NULL
cytokines	NULL
IL-6	NULL
and	NULL
TNF-	NULL
«	NULL
,	NULL
chemo-	NULL
100	NULL
fold	NULL
activation	NULL
S	NULL
Saline	NULL
s	NULL
+	NULL
=	NULL
+	NULL
=	NULL
TC	NULL
s	NULL
+	NULL
+	NULL
=	NULL
+	NULL
control	NULL
_	NULL
1	NULL
hour	NULL
6	NULL
hours	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Activator	NULL
protein-1	NULL
(	NULL
AP-1	NULL
)	NULL
activation	NULL
in	NULL
pancreatic	NULL
head	NULL
of	NULL
rats	NULL
from	NULL
control	NULL
,	NULL
saline	NULL
,	NULL
and	NULL
taurocholate	NULL
groups	NULL
at	NULL
1	NULL
and	NULL
6	NULL
h	NULL
after	NULL
intraductal	NULL
infusion	NULL
.	NULL

A	NULL
:	NULL
representative	NULL
EMSA	NULL
for	NULL
pancreatic	NULL
AP-1	NULL
binding	NULL
activity	NULL
.	NULL

B	NULL
:	NULL
levels	NULL
of	NULL
AP-1	NULL
activation	NULL
.	NULL

The	NULL
intensities	NULL
of	NULL
AP-1	NULL
bands	NULL
were	NULL
quantified	NULL
in	NULL
the	NULL
PhosphorImager	NULL
and	NULL
are	NULL
shown	NULL
for	NULL
each	NULL
group	NULL
as	NULL
means	NULL
+	NULL
SE	NULL
relative	NULL
to	NULL
control	NULL
;	NULL
n	NULL
=	NULL
3-6	NULL
animals/group	NULL
.	NULL

*Values	NULL
are	NULL
statistically	NULL
significantly	NULL
different	NULL
(	NULL
P	NULL
<	NULL
0.05	NULL
)	NULL
from	NULL
those	NULL
for	NULL
all	NULL
other	NULL
conditions	NULL
.	NULL

NS	NULL
,	NULL
nonspecific	NULL
.	NULL

Downloaded	NULL
from	NULL
www.physiclogy.org/journal/ajpgi	NULL
(	NULL
173.236.240.127	NULL
)	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

NF-KB	NULL
ACTIVATION	NULL
IN	NULL
TAUROCHOLATE	NULL
PANCREATITIS	NULL
&	NULL
&	NULL
RP	NULL
®	NULL
p	NULL
y	NULL
«	NULL
«	NULL
&	NULL
Aboo-	NULL
&	NULL
#	NULL
¥	NULL
y	NULL
\b	NULL
\b	NULL
#	NULL
®	NULL
se	NULL
wn	NULL
kines	NULL
KC	NULL
and	NULL
MCP-1	NULL
,	NULL
and	NULL
the	NULL
inflammatory	NULL
enzyme	NULL
iNOS	NULL
were	NULL
evaluated	NULL
by	NULL
semiquantitative	NULL
RT-PCR	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

The	NULL
values	NULL
were	NULL
expressed	NULL
relative	NULL
to	NULL
the	NULL
levels	NULL
in	NULL
saline-infused	NULL
rats	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
IL-6	NULL
,	NULL
KC	NULL
,	NULL
and	NULL
MCP-1	NULL
expression	NULL
were	NULL
not	NULL
or	NULL
were	NULL
barely	NULL
detectable	NULL
within	NULL
the	NULL
normal	NULL
pancreas	NULL
,	NULL
whereas	NULL
low	NULL
constitutive	NULL
levels	NULL
of	NULL
mRNA	NULL
were	NULL
observed	NULL
for	NULL
TNF-a	NULL
and	NULL
iNOS	NULL
.	NULL

After	NULL
the	NULL
infusion	NULL
of	NULL
taurocholate	NULL
,	NULL
IL-6	NULL
,	NULL
KC	NULL
,	NULL
and	NULL
MCP-1	NULL
were	NULL
upregulated	NULL
,	NULL
showing	NULL
increases	NULL
at	NULL
both	NULL
1	NULL
and	NULL
6	NULL
h.	NULL
In	NULL
comparison	NULL
,	NULL
an	NULL
increase	NULL
of	NULL
iNOS	NULL
mRNA	NULL
expression	NULL
was	NULL
delayed	NULL
,	NULL
showing	NULL
upregulation	NULL
at	NULL
6	NULL
h.	NULL
A	NULL
particularly	NULL
dramatic	NULL
increase	NULL
(	NULL
>	NULL
100-fold	NULL
)	NULL
was	NULL
observed	NULL
for	NULL
KC	NULL
mRNA	NULL
at	NULL
6	NULL
h	NULL
after	NULL
taurocholate	NULL
infusion	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
we	NULL
did	NULL
not	NULL
detect	NULL
significant	NULL
changes	NULL
in	NULL
TNF-a	NULL
expression	NULL
after	NULL
taurocholate	NULL
infusion	NULL
.	NULL

Saline	NULL
infusion	NULL
,	NULL
although	NULL
to	NULL
a	NULL
lesser	NULL
degree	NULL
than	NULL
taurocholate	NULL
infusion	NULL
,	NULL
also	NULL
increased	NULL
mRNA	NULL
expression	NULL
for	NULL
IL-6	NULL
,	NULL
KC	NULL
,	NULL
and	NULL
MCP-1	NULL
.	NULL

At	NULL
1	NULL
h	NULL
,	NULL
the	NULL
saline-induced	NULL
upregulation	NULL
of	NULL
IL-6	NULL
and	NULL
MCP-1	NULL
was	NULL
comparable	NULL
to	NULL
that	NULL
induced	NULL
by	NULL
taurocholate	NULL
infusion	NULL
.	NULL

Regional	NULL
Activation	NULL
of	NULL
NF-kB	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
Inflammatory	NULL
Molecule	NULL
Gene	NULL
Expression	NULL
in	NULL
the	NULL
Pancreas	NULL
Morphological	NULL
observations	NULL
(	NULL
this	NULL
study	NULL
and	NULL
Refs	NULL
.	NULL

31	NULL
and	NULL
46	NULL
)	NULL
show	NULL
that	NULL
retrograde	NULL
intraductal	NULL
infusion	NULL
of	NULL
taurocholate	NULL
causes	NULL
severe	NULL
tissue	NULL
damage	NULL
in	NULL
the	NULL
head	NULL
of	NULL
the	NULL
pancreas	NULL
with	NULL
preservation	NULL
of	NULL
the	NULL
pancreatic	NULL
tail	NULL
.	NULL

This	NULL
characteristic	NULL
of	NULL
the	NULL
model	NULL
led	NULL
us	NULL
to	NULL
investigate	NULL
whether	NULL
the	NULL
early	NULL
molecular	NULL
responses	NULL
displayed	NULL
a	NULL
similar	NULL
localized	NULL
profile	NULL
.	NULL

Representative	NULL
specimens	NULL
of	NULL
each	NULL
segment	NULL
(	NULL
head	NULL
or	NULL
tail	NULL
)	NULL
from	NULL
the	NULL
same	NULL
pancreas	NULL
were	NULL
collected	NULL
and	NULL
analyzed	NULL
separately	NULL
by	NULL
EMSA	NULL
and	NULL
RT-PCR	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

9A	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
was	NULL
much	NULL
stronger	NULL
in	NULL
the	NULL
head	NULL
segment	NULL
than	NULL
in	NULL
the	NULL
corresponding	NULL
tail	NULL
at	NULL
both	NULL
1	NULL
and	NULL
6	NULL
h	NULL
after	NULL
taurocholate	NULL
infusion	NULL
.	NULL

This	NULL
localized	NULL
activation	NULL
paralleled	NULL
the	NULL
more	NULL
intense	NULL
morphological	NULL
damage	NULL
,	NULL
neutrophil	NULL
infiltration	NULL
,	NULL
and	NULL
trypsin	NULL
activation	NULL
detected	NULL
in	NULL
the	NULL
same	NULL
pancreatic	NULL
segment	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
AP-1	NULL
showed	NULL
a	NULL
similar	NULL
increase	NULL
in	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
the	NULL
head	NULL
and	NULL
in	NULL
the	NULL
tail	NULL
after	NULL
taurocholate	NULL
infusion	NULL
(	NULL
Fig	NULL
.	NULL

9B	NULL
)	NULL
.	NULL

G12083	NULL
®	NULL
v	NULL
e	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

Subunit	NULL
composition	NULL
of	NULL
AP-1	NULL
complexes	NULL
in	NULL
pancreatic	NULL
head	NULL
of	NULL
rats	NULL
from	NULL
the	NULL
6-h	NULL
taurocholate	NULL
group	NULL
.	NULL

A	NULL
:	NULL
cold	NULL
competition	NULL
experiments	NULL
confirming	NULL
the	NULL
specificity	NULL
of	NULL
AP-1	NULL
by	NULL
adding	NULL
100	NULL
%	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
wild-type	NULL
(	NULL
cold	NULL
wt	NULL
)	NULL
or	NULL
unrelated	NULL
(	NULL
cold	NULL
unrelat	NULL
)	NULL
oligonucleotide	NULL
.	NULL

B	NULL
:	NULL
supershift	NULL
analysis	NULL
using	NULL
antibodies	NULL
to	NULL
indicated	NULL
AP-1	NULL
proteins	NULL
.	NULL

Arrow	NULL
shows	NULL
the	NULL
position	NULL
of	NULL
supershifted	NULL
band	NULL
.	NULL

Data	NULL
are	NULL
representative	NULL
of	NULL
2	NULL
animals	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
mRNA	NULL
expression	NULL
for	NULL
IL-6	NULL
,	NULL
MCP-1	NULL
,	NULL
iNOS	NULL
(	NULL
Fig	NULL
.	NULL

9C	NULL
)	NULL
,	NULL
and	NULL
KC	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
also	NULL
displayed	NULL
a	NULL
localized	NULL
response	NULL
,	NULL
with	NULL
strong	NULL
upregulation	NULL
in	NULL
the	NULL
head	NULL
of	NULL
the	NULL
pancreas	NULL
contrasting	NULL
the	NULL
absent	NULL
or	NULL
weak	NULL
expression	NULL
in	NULL
the	NULL
corresponding	NULL
tail	NULL
segment	NULL
.	NULL

Abrogation	NULL
of	NULL
the	NULL
Local	NULL
Inflammatory	NULL
Response	NULL
in	NULL
Taurocholate-Induced	NULL
Pancreatitis	NULL
by	NULL
NF-kB	NULL
Inhibition	NULL
To	NULL
determine	NULL
the	NULL
role	NULL
of	NULL
NF-	NULL
<	NULL
B	NULL
in	NULL
the	NULL
inflammatory	NULL
response	NULL
of	NULL
taurocholate	NULL
pancreatitis	NULL
,	NULL
rats	NULL
were	NULL
treated	NULL
with	NULL
an	NULL
NF-kB	NULL
inhibitor	NULL
,	NULL
the	NULL
antioxidant	NULL
NAC	NULL
(	NULL
15	NULL
,	NULL
17	NULL
,	NULL
51	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
activation	NULL
and	NULL
mRNA	NULL
expression	NULL
of	NULL
inflammatory	NULL
molecules	NULL
were	NULL
measured	NULL
in	NULL
pancreatic	NULL
head	NULL
specimens	NULL
collected	NULL
6	NULL
h	NULL
after	NULL
taurocholate	NULL
infusion	NULL
in	NULL
rats	NULL
treated	NULL
with	NULL
NAC	NULL
or	NULL
vehicle	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

10A	NULL
,	NULL
NAC	NULL
clearly	NULL
suppressed	NULL
pancreatic	NULL
NF-kB	NULL
activation	NULL
caused	NULL
by	NULL
taurocholate	NULL
infusion	NULL
.	NULL

NAC	NULL
inhibited	NULL
NF-	NULL
«	NULL
xB	NULL
activation	NULL
by	NULL
>	NULL
50	NULL
%	NULL
(	NULL
Fig	NULL
.	NULL

10B	NULL
)	NULL
.	NULL

Blockade	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
markedly	NULL
ameliorated	NULL
the	NULL
following	NULL
parameters	NULL
of	NULL
the	NULL
local	NULL
inflammatory	NULL
response	NULL
:	NULL
neutrophil	NULL
infiltration	NULL
(	NULL
Fig	NULL
.	NULL

10C	NULL
)	NULL
and	NULL
mRNA	NULL
expression	NULL
of	NULL
IL-6	NULL
,	NULL
KC	NULL
,	NULL
and	NULL
iNOS	NULL
(	NULL
Fig	NULL
.	NULL

10D	NULL
)	NULL
.	NULL

However	NULL
,	NULL
NAC	NULL
treatment	NULL
did	NULL
not	NULL
change	NULL
serum	NULL
amylase	NULL
and	NULL
lipase	NULL
levels	NULL
at	NULL
6	NULL
h	NULL
after	NULL
taurocholate	NULL
infusion	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

DISCUSSION	NULL
There	NULL
is	NULL
emerging	NULL
consensus	NULL
that	NULL
inflammatory	NULL
mediators	NULL
(	NULL
cytokines	NULL
,	NULL
in	NULL
particular	NULL
)	NULL
play	NULL
a	NULL
central	NULL
role	NULL
in	NULL
the	NULL
development	NULL
of	NULL
experimental	NULL
acute	NULL
pancreatitis	NULL
(	NULL
6	NULL
,	NULL
36	NULL
,	NULL
43	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
NF-	NULL
«	NULL
kB	NULL
has	NULL
been	NULL
identified	NULL
as	NULL
an	NULL
important	NULL
regulator	NULL
that	NULL
controls	NULL
the	NULL
expression	NULL
of	NULL
many	NULL
of	NULL
those	NULL
inflammatory	NULL
mediators	NULL
in	NULL
the	NULL
pancreas	NULL
(	NULL
9	NULL
,	NULL
17	NULL
,	NULL
19	NULL
,	NULL
39	NULL
,	NULL
44	NULL
,	NULL
52	NULL
)	NULL
.	NULL

These	NULL
molecular	NULL
events	NULL
have	NULL
been	NULL
studied	NULL
in	NULL
more	NULL
detail	NULL
in	NULL
the	NULL
rat	NULL
cerulein	NULL
model	NULL
of	NULL
pancreatitis	NULL
.	NULL

Administration	NULL
of	NULL
the	NULL
CCK	NULL
analog	NULL
cerulein	NULL
in	NULL
rats	NULL
causes	NULL
a	NULL
very	NULL
reproducible	NULL
but	NULL
mild	NULL
form	NULL
of	NULL
pancreatitis	NULL
limited	NULL
to	NULL
changes	NULL
in	NULL
the	NULL
pancreas	NULL
,	NULL
without	NULL
major	NULL
systemic	NULL
complications	NULL
or	NULL
lethality	NULL
(	NULL
1	NULL
,	NULL
26	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
taurocholate	NULL
infusion	NULL
into	NULL
the	NULL
rat	NULL
biliopancreatic	NULL
duct	NULL
is	NULL
associated	NULL
with	NULL
severe	NULL
local	NULL
pan	NULL
Downloaded	NULL
from	NULL
www.physiclogy.org/journal/ajpgi	NULL
(	NULL
173.236.240.127	NULL
)	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

G1204	NULL
creatic	NULL
damage	NULL
(	NULL
edema	NULL
,	NULL
necrosis	NULL
,	NULL
hemorrhage	NULL
,	NULL
and	NULL
abundant	NULL
leukocyte	NULL
infiltration	NULL
)	NULL
,	NULL
major	NULL
systemic	NULL
com-plications	NULL
,	NULL
and	NULL
high	NULL
mortality	NULL
(	NULL
2	NULL
)	NULL
.	NULL

This	NULL
model	NULL
closely	NULL
reproduces	NULL
the	NULL
necrohemorrhagic	NULL
pancreatitis	NULL
in	NULL
humans	NULL
(	NULL
27	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
chose	NULL
the	NULL
taurocholate-induced	NULL
pancreatitis	NULL
model	NULL
to	NULL
investigate	NULL
whether	NULL
the	NULL
above-described	NULL
molecular	NULL
events	NULL
are	NULL
common	NULL
between	NULL
different	NULL
experimental	NULL
models	NULL
and	NULL
,	NULL
Time	NULL
1	NULL
hour	NULL
6	NULL
hours	NULL
are	NULL
.	NULL

Poop	NULL
EH	NULL
__	NULL
-	NULL
-	NULL
]	NULL
|___	NULL
--	NULL
-	NULL
saa	NULL
2	NULL
*	NULL
#	NULL
*	NULL
5	NULL
1	NULL
&	NULL
3	NULL
1	NULL
1	NULL
1	NULL
«	NULL
<	NULL
R	NULL
e	NULL
:	NULL
:	NULL
5	NULL
£4	NULL
*	NULL
#	NULL
200	NULL
3	NULL
100	NULL
1	NULL
1	NULL
3	NULL
*	NULL
#	NULL
*	NULL
#	NULL
7	NULL
4	NULL
1	NULL
1	NULL
iNOS	NULL
Hg	NULL
aa	NULL
a	NULL
Cont	NULL
Saline	NULL
TC	NULL
Cont	NULL
Saline	NULL
TC	NULL
NF-KB	NULL
ACTIVATION	NULL
IN	NULL
TAUROCHOLATE	NULL
PANCREATITIS	NULL
hence	NULL
,	NULL
represent	NULL
a	NULL
common	NULL
pathway	NULL
in	NULL
the	NULL
early	NULL
phase	NULL
of	NULL
the	NULL
disease	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
NF-	NULL
<	NULL
B	NULL
,	NULL
we	NULL
also	NULL
studied	NULL
AP-1	NULL
,	NULL
another	NULL
important	NULL
transcription	NULL
factor	NULL
in	NULL
the	NULL
early	NULL
inflammatory	NULL
response	NULL
(	NULL
15	NULL
,	NULL
50	NULL
)	NULL
.	NULL

Because	NULL
in	NULL
the	NULL
taurocholate	NULL
model	NULL
the	NULL
damage	NULL
is	NULL
mostly	NULL
localized	NULL
to	NULL
the	NULL
pancreatic	NULL
head	NULL
,	NULL
we	NULL
asked	NULL
whether	NULL
activation	NULL
of	NULL
transcription	NULL
factors	NULL
and	NULL
inflammatory	NULL
molecules	NULL
correlated	NULL
with	NULL
parameters	NULL
of	NULL
pancreatitis	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
analyzed	NULL
responses	NULL
to	NULL
the	NULL
mechanical	NULL
effect	NULL
of	NULL
saline	NULL
intraductal	NULL
infusion	NULL
.	NULL

Morphologically	NULL
,	NULL
taurocholate	NULL
infusion	NULL
caused	NULL
severe	NULL
pancreatic	NULL
damage	NULL
in	NULL
the	NULL
head	NULL
of	NULL
the	NULL
pancreas	NULL
,	NULL
evident	NULL
at	NULL
both	NULL
1	NULL
and	NULL
6	NULL
h	NULL
after	NULL
the	NULL
infusion	NULL
.	NULL

This	NULL
was	NULL
accompanied	NULL
by	NULL
a	NULL
progressive	NULL
increase	NULL
in	NULL
serum	NULL
amylase	NULL
and	NULL
lipase	NULL
,	NULL
pancreatic	NULL
neutrophil	NULL
infiltration	NULL
,	NULL
and	NULL
trypsin	NULL
activation	NULL
in	NULL
the	NULL
head	NULL
segment	NULL
of	NULL
the	NULL
gland	NULL
.	NULL

After	NULL
a	NULL
parallel	NULL
time	NULL
course	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
rapidly	NULL
activated	NULL
in	NULL
the	NULL
pancreatic	NULL
head	NULL
,	NULL
with	NULL
increasing	NULL
activation	NULL
at	NULL
6	NULL
h	NULL
after	NULL
taurocholate	NULL
infusion	NULL
.	NULL

These	NULL
observations	NULL
extend	NULL
previous	NULL
findings	NULL
of	NULL
early	NULL
pancreatic	NULL
activation	NULL
in	NULL
the	NULL
rat	NULL
cerulein	NULL
model	NULL
(	NULL
17	NULL
,	NULL
44	NULL
)	NULL
and	NULL
in	NULL
pancreatitis	NULL
induced	NULL
by	NULL
occlusion	NULL
of	NULL
the	NULL
pancreatic	NULL
duct	NULL
(	NULL
9	NULL
)	NULL
.	NULL

In	NULL
those	NULL
studies	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
was	NULL
detected	NULL
within	NULL
the	NULL
first	NULL
15	NULL
min	NULL
of	NULL
cerulein	NULL
induction	NULL
(	NULL
17	NULL
,	NULL
44	NULL
)	NULL
and	NULL
1	NULL
h	NULL
after	NULL
pancreatic	NULL
duct	NULL
occlusion	NULL
(	NULL
9	NULL
)	NULL
.	NULL

NF-	NULL
<	NULL
B	NULL
activation	NULL
has	NULL
also	NULL
been	NULL
reported	NULL
in	NULL
peritoneal	NULL
and	NULL
alveolar	NULL
macrophages	NULL
from	NULL
rats	NULL
with	NULL
taurocholate-induced	NULL
pancreatitis	NULL
(	NULL
42	NULL
)	NULL
.	NULL

With	NULL
the	NULL
supershift	NULL
assay	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
p65	NULL
(	NULL
Rel	NULL
A	NULL
)	NULL
and	NULL
p50	NULL
subunits	NULL
are	NULL
present	NULL
in	NULL
the	NULL
activated	NULL
NF-	NULL
<	NULL
B	NULL
complexes	NULL
in	NULL
taurocholate	NULL
pancreatitis	NULL
.	NULL

We	NULL
im-munolocalized	NULL
the	NULL
translocated	NULL
p65	NULL
subunit	NULL
to	NULL
the	NULL
acinar	NULL
cell	NULL
nuclei	NULL
.	NULL

p65	NULL
translocation	NULL
into	NULL
acinar	NULL
cell	NULL
nuclei	NULL
has	NULL
been	NULL
also	NULL
observed	NULL
in	NULL
the	NULL
cerulein	NULL
model	NULL
(	NULL
44	NULL
)	NULL
.	NULL

Although	NULL
neutrophil	NULL
infiltration	NULL
into	NULL
the	NULL
pancreas	NULL
was	NULL
abundant	NULL
6	NULL
h	NULL
after	NULL
taurocholate	NULL
infusion	NULL
,	NULL
the	NULL
immunostaining	NULL
revealed	NULL
that	NULL
the	NULL
main	NULL
source	NULL
of	NULL
nuclear	NULL
p65	NULL
was	NULL
the	NULL
acinar	NULL
cells	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
the	NULL
acinar	NULL
cells	NULL
represents	NULL
a	NULL
primary	NULL
event	NULL
in	NULL
the	NULL
early	NULL
phase	NULL
of	NULL
acute	NULL
pancreatitis	NULL
.	NULL

The	NULL
finding	NULL
of	NULL
pancreatic	NULL
NF-kB	NULL
activation	NULL
in	NULL
several	NULL
experimental	NULL
models	NULL
of	NULL
pancreatitis	NULL
indicates	NULL
that	NULL
NF-	NULL
<	NULL
B	NULL
activation	NULL
may	NULL
be	NULL
an	NULL
important	NULL
common	NULL
mechanism	NULL
in	NULL
the	NULL
development	NULL
of	NULL
acute	NULL
pancreatitis	NULL
.	NULL

We	NULL
observed	NULL
a	NULL
strong	NULL
AP-1	NULL
response	NULL
already	NULL
at	NULL
1	NULL
h	NULL
after	NULL
taurocholate	NULL
infusion	NULL
.	NULL

However	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
AP-1	NULL
binding	NULL
activity	NULL
in	NULL
the	NULL
pancreas	NULL
did	NULL
not	NULL
Fig	NULL
.	NULL

8	NULL
.	NULL

Semiquantitative	NULL
RT-PCR	NULL
analysis	NULL
of	NULL
mRNA	NULL
expression	NULL
for	NULL
cytokines	NULL
,	NULL
chemokines	NULL
,	NULL
and	NULL
iNOS	NULL
in	NULL
pancreatic	NULL
head	NULL
of	NULL
rats	NULL
from	NULL
control	NULL
,	NULL
saline	NULL
,	NULL
and	NULL
taurocholate	NULL
groups	NULL
at	NULL
1	NULL
and	NULL
6	NULL
h	NULL
after	NULL
the	NULL
intraductal	NULL
infusion	NULL
.	NULL

Shown	NULL
are	NULL
representative	NULL
RT-PCR	NULL
for	NULL
expression	NULL
of	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
-6	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
LNF	NULL
)	NULL
-	NULL
«	NULL
,	NULL
KC	NULL
,	NULL
monocyte	NULL
chemoattractant	NULL
protein	NULL
(	NULL
MCP	NULL
)	NULL
-1	NULL
,	NULL
inducible	NULL
nitric	NULL
oxide	NULL
synthase	NULL
(	NULL
iNOS	NULL
)	NULL
,	NULL
and	NULL
the	NULL
housekeeping	NULL
gene	NULL
acidic	NULL
ribosomal	NULL
phosphoprotein	NULL
PO	NULL
(	NULL
ARP	NULL
)	NULL
in	NULL
the	NULL
pancreatic	NULL
tissue	NULL
.	NULL

Bars	NULL
represent	NULL
densitometric	NULL
analysis	NULL
of	NULL
RT-PCR	NULL
products	NULL
.	NULL

The	NULL
densities	NULL
of	NULL
RT-PCR	NULL
products	NULL
were	NULL
normalized	NULL
to	NULL
those	NULL
of	NULL
the	NULL
housekeeping	NULL
gene	NULL
ARP	NULL
in	NULL
the	NULL
same	NULL
cDNA	NULL
samples	NULL
.	NULL

Values	NULL
are	NULL
means	NULL
+	NULL
SE	NULL
for	NULL
3-6	NULL
animals/	NULL
group	NULL
and	NULL
are	NULL
given	NULL
relative	NULL
to	NULL
the	NULL
saline	NULL
group	NULL
.	NULL

*Values	NULL
are	NULL
statistically	NULL
significantly	NULL
greater	NULL
(	NULL
P	NULL
<	NULL
0.05	NULL
)	NULL
than	NULL
for	NULL
control	NULL
group	NULL
.	NULL

#	NULL
Values	NULL
are	NULL
statistically	NULL
significantly	NULL
greater	NULL
(	NULL
P	NULL
<	NULL
0.05	NULL
)	NULL
than	NULL
for	NULL
saline	NULL
group	NULL
.	NULL

Downloaded	NULL
from	NULL
www.physiclogy.org/journal/ajpgi	NULL
(	NULL
173.236.240.127	NULL
)	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

NF-KB	NULL
ACTIVATION	NULL
IN	NULL
TAUROCHOLATE	NULL
PANCREATITIS	NULL
G1205	NULL
A	NULL
B	NULL
c	NULL
Animal	NULL
1	NULL
2	NULL
3	NULL
_	NULL
4	NULL
1	NULL
2	NULL
3	NULL
-	NULL
4	NULL
1	NULL
2	NULL
o*	NULL
-r	NULL
--	NULL
r—bHr—	NULL
‘	NULL
ﬂ	NULL
m~-*	NULL
--	NULL
*-	NULL
a-	NULL
A	NULL
r	NULL
P.	NULL
i	NULL
&	NULL
a=	NULL
&	NULL
=	NULL
&	NULL
&	NULL
Fe	NULL
Fa	NULL
&	NULL
33	NULL
3	NULL
5	NULL
p	NULL
a	NULL
Pel	NULL
§	NULL
segment	NULL
.	NULL

*4	NULL
44	NULL
Es	NULL
E2	NULL
da	NULL
irs	NULL
bs	NULL
$	NULL
a	NULL
4	NULL
&	NULL
$	NULL
5	NULL
NF-kB	NULL
-	NULL
»	NULL
u	NULL
i	NULL
1	NULL
hour	NULL
6	NULL
hours	NULL
U	NULL
Ap-1-	NULL
»	NULL
Wh	NULL
ba	NULL
)	NULL
luk	NULL
bad	NULL
``	NULL
an	NULL
“	NULL
1	NULL
hour	NULL
are	NULL
-	NULL
Eo	NULL
vor-	NULL
pany	NULL
nos	NULL
-	NULL
Poems	NULL
6	NULL
hours	NULL
IL-6	NULL
6	NULL
hours	NULL
Fig	NULL
.	NULL

9	NULL
.	NULL

Regional	NULL
activation	NULL
of	NULL
NF-kB	NULL
and	NULL
AP-1	NULL
and	NULL
cytokine	NULL
mRNA	NULL
expression	NULL
in	NULL
pancreatic	NULL
head	NULL
and	NULL
tail	NULL
of	NULL
rats	NULL
from	NULL
taurocholate	NULL
group	NULL
.	NULL

A	NULL
and	NULL
B	NULL
:	NULL
representative	NULL
EMSA	NULL
showing	NULL
much	NULL
greater	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
the	NULL
pancreatic	NULL
head	NULL
than	NULL
in	NULL
the	NULL
corresponding	NULL
tail	NULL
(	NULL
4	NULL
)	NULL
and	NULL
similar	NULL
AP-1	NULL
activation	NULL
in	NULL
both	NULL
pancreatic	NULL
segments	NULL
(	NULL
B	NULL
)	NULL
.	NULL

C	NULL
:	NULL
representative	NULL
RT-PCR	NULL
showing	NULL
localized	NULL
mRNA	NULL
upregulation	NULL
for	NULL
cytokines	NULL
and	NULL
iNOS	NULL
in	NULL
the	NULL
pancreatic	NULL
head	NULL
compared	NULL
with	NULL
the	NULL
corresponding	NULL
tail	NULL
.	NULL

further	NULL
increase	NULL
at	NULL
6	NULL
h	NULL
after	NULL
taurocholate	NULL
infusion	NULL
.	NULL

Different	NULL
homo-	NULL
and	NULL
heterodimeric	NULL
AP-1	NULL
complexes	NULL
can	NULL
differently	NULL
regulate	NULL
transcription	NULL
of	NULL
target	NULL
genes	NULL
(	NULL
50	NULL
)	NULL
.	NULL

Our	NULL
supershift	NULL
assay	NULL
demonstrated	NULL
the	NULL
presence	NULL
of	NULL
c-Fos	NULL
,	NULL
Jun-B	NULL
,	NULL
and	NULL
Fra-2	NULL
in	NULL
the	NULL
AP-1	NULL
complexes	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
taurocholate	NULL
infusion	NULL
.	NULL

AP-1	NULL
activation	NULL
in	NULL
the	NULL
pancreas	NULL
has	NULL
not	NULL
been	NULL
described	NULL
previ-ously	NULL
.	NULL

So	NULL
far	NULL
,	NULL
two	NULL
studies	NULL
reported	NULL
pancreatic	NULL
induction	NULL
of	NULL
the	NULL
protoncogenes	NULL
c-fos	NULL
and	NULL
c-jun	NULL
during	NULL
cerulein-induced	NULL
pancreatitis	NULL
in	NULL
mice	NULL
(	NULL
13	NULL
)	NULL
and	NULL
rats	NULL
(	NULL
10	NULL
)	NULL
.	NULL

The	NULL
role	NULL
of	NULL
the	NULL
different	NULL
AP-1	NULL
subunits	NULL
we	NULL
found	NULL
activated	NULL
in	NULL
taurocholate	NULL
pancreatitis	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
genes	NULL
mediating	NULL
the	NULL
inflammatory	NULL
response	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

We	NULL
measured	NULL
the	NULL
pancreatic	NULL
mRNA	NULL
expression	NULL
of	NULL
proinflammatory	NULL
cytokines	NULL
(	NULL
IL-6	NULL
and	NULL
TNF-a	NULL
)	NULL
,	NULL
chemo-kines	NULL
(	NULL
KC	NULL
and	NULL
MCP-1	NULL
)	NULL
,	NULL
and	NULL
iNOS	NULL
in	NULL
saline-	NULL
and	NULL
taurocholate-infused	NULL
rats	NULL
.	NULL

Promoters	NULL
of	NULL
all	NULL
of	NULL
these	NULL
genes	NULL
contain	NULL
binding	NULL
sites	NULL
for	NULL
NF-	NULL
«	NULL
kB	NULL
and	NULL
AP-1	NULL
(	NULL
4	NULL
,	NULL
38	NULL
,	NULL
34	NULL
,	NULL
40	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
show	NULL
that	NULL
taurocholate	NULL
pancreatitis	NULL
is	NULL
A	NULL
C	NULL
D	NULL
NAC	NULL
|	NULL
=-	NULL
=-	NULL
+	NULL
+	NULL
186	NULL
NAC	NULL
=	NULL
=-	NULL
-	NULL
+	NULL
+	NULL
+	NULL
-	NULL
E	NULL
&	NULL
4	NULL
|	NULL
e	NULL
mopp	NULL
ace	NULL
u	NULL
NH	NULL
3	NULL
5.	NULL
o	NULL
B	NULL
s	NULL
*	NULL
5	NULL
I	NULL
1	NULL
5	NULL
NAC	NULL
-	NULL
+	NULL
6	NULL
<	NULL
T	NULL
3	NULL
z	NULL
o	NULL
LL	NULL
0	NULL
NAC	NULL
=	NULL
+	NULL
Fig	NULL
.	NULL

10	NULL
.	NULL

Effect	NULL
of	NULL
N-acetylcysteine	NULL
(	NULL
NAC	NULL
)	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
,	NULL
neutrophil	NULL
infiltration	NULL
(	NULL
C	NULL
)	NULL
,	NULL
and	NULL
mRNA	NULL
expression	NULL
of	NULL
inflammatory	NULL
molecules	NULL
(	NULL
D	NULL
)	NULL
in	NULL
6-h	NULL
taurocholate	NULL
pancreatitis	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
taurocholate	NULL
treatment	NULL
,	NULL
rats	NULL
received	NULL
NAC	NULL
or	NULL
saline	NULL
iv	NULL
infusion	NULL
as	NULL
described	NULL
in	NULL
MATERIALS	NULL
AND	NULL
METHODS	NULL
.	NULL

A	NULL
:	NULL
representative	NULL
EMSA	NULL
showing	NULL
inhibition	NULL
of	NULL
NF-kB	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
pancreata	NULL
of	NULL
rats	NULL
treated	NULL
with	NULL
NAC	NULL
.	NULL

B	NULL
:	NULL
intensities	NULL
of	NULL
the	NULL
NF-kB	NULL
band	NULL
were	NULL
quantified	NULL
in	NULL
the	NULL
PhosphorImager	NULL
and	NULL
are	NULL
shown	NULL
as	NULL
means	NULL
+	NULL
SE	NULL
for	NULL
the	NULL
taurocholate	NULL
+	NULL
NAC	NULL
group	NULL
(	NULL
open	NULL
bar	NULL
)	NULL
relative	NULL
to	NULL
the	NULL
taurocholate	NULL
+	NULL
saline	NULL
group	NULL
(	NULL
solid	NULL
bar	NULL
)	NULL
(	NULL
n	NULL
=	NULL
4	NULL
)	NULL
.	NULL

C	NULL
:	NULL
pancreatic	NULL
neutrophil	NULL
infiltration	NULL
.	NULL

*P	NULL
<	NULL
0.05	NULL
compared	NULL
with	NULL
the	NULL
taurocholate	NULL
+	NULL
saline	NULL
group	NULL
.	NULL

D	NULL
:	NULL
representative	NULL
RT-PCR	NULL
for	NULL
pancreatic	NULL
expression	NULL
of	NULL
the	NULL
housekeeping	NULL
gene	NULL
ARP	NULL
,	NULL
cytokine	NULL
IL-6	NULL
,	NULL
chemokine	NULL
KC	NULL
,	NULL
and	NULL
iNOS	NULL
.	NULL

Values	NULL
are	NULL
means	NULL
+	NULL
SE	NULL
of	NULL
4	NULL
animals	NULL
in	NULL
each	NULL
group	NULL
.	NULL

Downloaded	NULL
from	NULL
www.physiclogy.org/journal/ajpgi	NULL
(	NULL
173.236.240.127	NULL
)	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

G1206	NULL
associated	NULL
with	NULL
an	NULL
early	NULL
upregulation	NULL
in	NULL
the	NULL
head	NULL
of	NULL
the	NULL
pancreas	NULL
of	NULL
all	NULL
the	NULL
mediators	NULL
studied	NULL
except	NULL
TNF-a	NULL
.	NULL

Because	NULL
TNF-a	NULL
induction	NULL
has	NULL
been	NULL
reported	NULL
for	NULL
other	NULL
models	NULL
of	NULL
pancreatitis	NULL
(	NULL
9	NULL
,	NULL
13	NULL
,	NULL
16	NULL
,	NULL
38	NULL
)	NULL
,	NULL
this	NULL
finding	NULL
may	NULL
be	NULL
dependent	NULL
on	NULL
the	NULL
specific	NULL
characteristics	NULL
of	NULL
taurocholate-induced	NULL
pancreatitis	NULL
.	NULL

It	NULL
also	NULL
may	NULL
be	NULL
that	NULL
TNF-a	NULL
activation	NULL
in	NULL
this	NULL
model	NULL
is	NULL
delayed	NULL
beyond	NULL
the	NULL
6-h	NULL
observation	NULL
period	NULL
.	NULL

Of	NULL
particular	NULL
interest	NULL
is	NULL
the	NULL
strong	NULL
upregulation	NULL
we	NULL
observed	NULL
for	NULL
the	NULL
chemokine	NULL
KC	NULL
,	NULL
a	NULL
potent	NULL
neutrophil	NULL
chemoattractant	NULL
(	NULL
80	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
other	NULL
experimental	NULL
models	NULL
of	NULL
acute	NULL
pancreatitis	NULL
,	NULL
in	NULL
which	NULL
the	NULL
pancreas	NULL
is	NULL
entirely	NULL
affected	NULL
,	NULL
the	NULL
intraductal	NULL
infusion	NULL
of	NULL
taurocholate	NULL
renders	NULL
a	NULL
regional	NULL
affectation	NULL
mostly	NULL
limited	NULL
to	NULL
the	NULL
pancreatic	NULL
head	NULL
.	NULL

Such	NULL
localized	NULL
damage	NULL
is	NULL
an	NULL
inherent	NULL
characteristic	NULL
of	NULL
this	NULL
model	NULL
.	NULL

This	NULL
and	NULL
previous	NULL
studies	NULL
(	NULL
25	NULL
,	NULL
31	NULL
,	NULL
45	NULL
,	NULL
46	NULL
)	NULL
show	NULL
more	NULL
pronounced	NULL
morphological	NULL
injury	NULL
;	NULL
,	NULL
microcirculatory	NULL
changes	NULL
,	NULL
trypsin	NULL
activation	NULL
,	NULL
and	NULL
neutrophil	NULL
infiltration	NULL
in	NULL
the	NULL
pancreatic	NULL
head	NULL
than	NULL
in	NULL
the	NULL
tail	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
found	NULL
a	NULL
localized	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
expression	NULL
of	NULL
inflammatory	NULL
molecules	NULL
in	NULL
the	NULL
pancreatic	NULL
head	NULL
.	NULL

The	NULL
correlation	NULL
between	NULL
regional	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
and	NULL
the	NULL
cytokines	NULL
regulated	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
and	NULL
the	NULL
parameters	NULL
that	NULL
reflect	NULL
pancreatic	NULL
damage	NULL
adds	NULL
new	NULL
evidence	NULL
to	NULL
the	NULL
key	NULL
role	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
in	NULL
tissue	NULL
injury	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
NF-	NULL
<	NULL
B	NULL
,	NULL
there	NULL
was	NULL
not	NULL
much	NULL
difference	NULL
in	NULL
AP-1	NULL
activation	NULL
between	NULL
the	NULL
pancreatic	NULL
head	NULL
and	NULL
tail	NULL
.	NULL

Also	NULL
,	NULL
the	NULL
increase	NULL
in	NULL
AP-1-binding	NULL
activity	NULL
was	NULL
similar	NULL
in	NULL
saline-and	NULL
taurocholate-infused	NULL
rats	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
,	NULL
although	NULL
AP-1	NULL
may	NULL
be	NULL
necessary	NULL
for	NULL
the	NULL
full	NULL
activation	NULL
of	NULL
specific	NULL
inflammatory	NULL
molecules	NULL
,	NULL
it	NULL
is	NULL
not	NULL
sufficient	NULL
by	NULL
itself	NULL
to	NULL
do	NULL
so	NULL
.	NULL

To	NULL
establish	NULL
whether	NULL
the	NULL
changes	NULL
observed	NULL
in	NULL
taurocholate-induced	NULL
pancreatitis	NULL
were	NULL
dependent	NULL
on	NULL
NF-KB	NULL
activity	NULL
,	NULL
we	NULL
used	NULL
the	NULL
NF-kB	NULL
inhibitor	NULL
NAC	NULL
.	NULL

This	NULL
antioxidant	NULL
is	NULL
well	NULL
known	NULL
to	NULL
inhibit	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
vivo	NULL
(	NULL
15	NULL
,	NULL
17	NULL
,	NULL
51	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
what	NULL
we	NULL
previously	NULL
reported	NULL
for	NULL
cerulein	NULL
pancreatitis	NULL
(	NULL
17	NULL
)	NULL
,	NULL
NAC	NULL
markedly	NULL
inhibited	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
the	NULL
6	NULL
h	NULL
of	NULL
taurocholate	NULL
pancreatitis	NULL
,	NULL
with	NULL
significant	NULL
amelioration	NULL
of	NULL
the	NULL
local	NULL
inflammatory	NULL
response	NULL
(	NULL
neutrophil	NULL
infiltration	NULL
and	NULL
expression	NULL
of	NULL
inflammatory	NULL
molecules	NULL
)	NULL
.	NULL

This	NULL
finding	NULL
supports	NULL
the	NULL
idea	NULL
that	NULL
NF-	NULL
<	NULL
B	NULL
activation	NULL
is	NULL
a	NULL
key	NULL
event	NULL
in	NULL
triggering	NULL
the	NULL
local	NULL
cascade	NULL
of	NULL
inflammatory	NULL
mediators	NULL
associated	NULL
with	NULL
acute	NULL
pancreatitis	NULL
.	NULL

NAC	NULL
did	NULL
not	NULL
affect	NULL
serum	NULL
amylase	NULL
and	NULL
lipase	NULL
levels	NULL
at	NULL
6	NULL
h	NULL
after	NULL
taurocholate	NULL
infusion	NULL
.	NULL

This	NULL
finding	NULL
may	NULL
be	NULL
explained	NULL
by	NULL
the	NULL
multifactorial	NULL
nature	NULL
of	NULL
pancreatic	NULL
injury	NULL
associated	NULL
with	NULL
the	NULL
taurocholate	NULL
model	NULL
,	NULL
one	NULL
of	NULL
the	NULL
factors	NULL
being	NULL
``	NULL
mechanical	NULL
``	NULL
injury	NULL
.	NULL

Once	NULL
the	NULL
integrity	NULL
of	NULL
the	NULL
panere-atic	NULL
tissue	NULL
is	NULL
disrupted	NULL
by	NULL
the	NULL
direct	NULL
action	NULL
of	NULL
the	NULL
taurocholic	NULL
bile	NULL
salt	NULL
,	NULL
pancreatic	NULL
enzymes	NULL
may	NULL
reach	NULL
the	NULL
circulation	NULL
independently	NULL
of	NULL
any	NULL
mechanism	NULL
regulating	NULL
the	NULL
inflammatory	NULL
process	NULL
.	NULL

The	NULL
absence	NULL
of	NULL
such	NULL
mechanical	NULL
factors	NULL
in	NULL
cerulein	NULL
pancreatitis	NULL
may	NULL
account	NULL
for	NULL
the	NULL
observation	NULL
of	NULL
a	NULL
greater	NULL
effect	NULL
of	NULL
NAC	NULL
on	NULL
serum	NULL
amylase	NULL
and	NULL
lipase	NULL
in	NULL
the	NULL
cerulein	NULL
model	NULL
(	NULL
17	NULL
)	NULL
.	NULL

It	NULL
is	NULL
of	NULL
note	NULL
that	NULL
the	NULL
beneficial	NULL
effects	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
cytokine	NULL
inhibition	NULL
may	NULL
also	NULL
be	NULL
pronounced	NULL
at	NULL
later	NULL
stages	NULL
of	NULL
taurocholate-induced	NULL
pancreatitis	NULL
.	NULL

Inhibition	NULL
NF-KB	NULL
ACTIVATION	NULL
IN	NULL
TAUROCHOLATE	NULL
PANCREATITIS	NULL
of	NULL
NF-kB	NULL
with	NULL
another	NULL
antioxidant	NULL
,	NULL
pyrrolidinedithio-carbamate	NULL
,	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
improve	NULL
the	NULL
survival	NULL
of	NULL
rats	NULL
with	NULL
taurocholate	NULL
pancreatitis	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Our	NULL
study	NULL
focused	NULL
on	NULL
the	NULL
early	NULL
events	NULL
in	NULL
this	NULL
model	NULL
.	NULL

Finally	NULL
,	NULL
our	NULL
data	NULL
provide	NULL
characterization	NULL
of	NULL
some	NULL
molecular	NULL
events	NULL
in	NULL
the	NULL
pancreatic	NULL
response	NULL
to	NULL
saline	NULL
intraductal	NULL
infusion	NULL
.	NULL

Saline	NULL
infusion	NULL
into	NULL
the	NULL
pancreatic	NULL
duct	NULL
is	NULL
not	NULL
a	NULL
harmless	NULL
procedure	NULL
(	NULL
2	NULL
,	NULL
31	NULL
,	NULL
45	NULL
)	NULL
.	NULL

The	NULL
hydrostatic	NULL
pressure	NULL
increase	NULL
is	NULL
one	NULL
of	NULL
several	NULL
factors	NULL
that	NULL
can	NULL
trigger	NULL
the	NULL
inflammatory	NULL
reaction	NULL
in	NULL
the	NULL
pancreas	NULL
(	NULL
82	NULL
)	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
intraductal	NULL
saline	NULL
infusion	NULL
may	NULL
be	NULL
extrapolated	NULL
to	NULL
the	NULL
endoscopic	NULL
retrograde	NULL
cholangiopancreatography	NULL
used	NULL
in	NULL
humans	NULL
that	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
risk	NULL
of	NULL
pancreatitis	NULL
(	NULL
18	NULL
,	NULL
29	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
although	NULL
saline	NULL
infusion	NULL
did	NULL
not	NULL
cause	NULL
the	NULL
necrohemorrhagic	NULL
changes	NULL
as	NULL
observed	NULL
after	NULL
taurocholate	NULL
infusion	NULL
,	NULL
it	NULL
did	NULL
induce	NULL
significant	NULL
hyperamy-lasemia	NULL
and	NULL
hyperlipasemia	NULL
,	NULL
inflammatory	NULL
cell	NULL
infiltration	NULL
,	NULL
and	NULL
trypsin	NULL
activation	NULL
in	NULL
the	NULL
head	NULL
of	NULL
the	NULL
pancreas	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
observed	NULL
saline-induced	NULL
activation	NULL
of	NULL
NF-kB	NULL
and	NULL
some	NULL
cytokines/chemokines	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
IL-6	NULL
,	NULL
KC	NULL
,	NULL
and	NULL
MCP-1	NULL
)	NULL
in	NULL
response	NULL
to	NULL
saline	NULL
infusion	NULL
.	NULL

A	NULL
particularly	NULL
strong	NULL
activation	NULL
was	NULL
observed	NULL
for	NULL
AP-1	NULL
,	NULL
which	NULL
was	NULL
comparable	NULL
to	NULL
that	NULL
induced	NULL
by	NULL
taurocholate	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
an	NULL
increase	NULL
in	NULL
intrapancreatic	NULL
hydrostatic	NULL
pressure	NULL
in	NULL
itself	NULL
can	NULL
trigger	NULL
some	NULL
pathways	NULL
initiating	NULL
an	NULL
inflammatory	NULL
response	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
our	NULL
study	NULL
demonstrated	NULL
that	NULL
taurocholate	NULL
infusion	NULL
results	NULL
in	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
NF-	NULL
«	NULL
kB	NULL
and	NULL
AP-1	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
proinflammatory	NULL
cytokines/chemokines	NULL
and	NULL
iNOS	NULL
in	NULL
the	NULL
pancreas	NULL
.	NULL

NF-	NULL
<	NULL
kB	NULL
(	NULL
but	NULL
not	NULL
AP-1	NULL
)	NULL
activation	NULL
and	NULL
upregulation	NULL
of	NULL
proinflammatory	NULL
molecules	NULL
were	NULL
more	NULL
pronounced	NULL
in	NULL
the	NULL
head	NULL
than	NULL
in	NULL
the	NULL
tail	NULL
segment	NULL
of	NULL
the	NULL
pancreas	NULL
.	NULL

The	NULL
localized	NULL
responses	NULL
correlated	NULL
with	NULL
the	NULL
severity	NULL
of	NULL
the	NULL
lesion	NULL
,	NULL
including	NULL
morphological	NULL
changes	NULL
,	NULL
neutrophil	NULL
infiltration	NULL
,	NULL
and	NULL
pancreatic	NULL
trypsin	NULL
activation	NULL
.	NULL

Inhibition	NULL
of	NULL
NF-	NULL
<	NULL
B	NULL
activation	NULL
resulted	NULL
in	NULL
amelioration	NULL
of	NULL
the	NULL
local	NULL
inflammatory	NULL
response	NULL
.	NULL

Intraductal	NULL
saline	NULL
infusion	NULL
also	NULL
caused	NULL
morphological	NULL
and	NULL
molecular	NULL
changes	NULL
that	NULL
reflect	NULL
pancreatic	NULL
injury	NULL
,	NULL
although	NULL
much	NULL
milder	NULL
compared	NULL
with	NULL
taurocholate	NULL
infusion	NULL
.	NULL

The	NULL
results	NULL
indicate	NULL
that	NULL
activation	NULL
of	NULL
transcription	NULL
factors	NULL
and	NULL
inflammatory	NULL
molecule	NULL
expression	NULL
is	NULL
a	NULL
common	NULL
mechanism	NULL
in	NULL
the	NULL
development	NULL
of	NULL
acute	NULL
pancreatitis	NULL
in	NULL
different	NULL
models	NULL
of	NULL
pancreatitis	NULL
.	NULL

This	NULL
study	NULL
was	NULL
supported	NULL
by	NULL
Grant	NULL
FIS	NULL
98/5072	NULL
from	NULL
the	NULL
Ministry	NULL
of	NULL
Health	NULL
,	NULL
Spain	NULL
(	NULL
to	NULL
E.	NULL
Vaquero	NULL
)	NULL
,	NULL
the	NULL
Department	NULL
of	NULL
Veterans	NULL
Affairs	NULL
,	NULL
The	NULL
Research	NULL
Center	NULL
for	NULL
Alcoholic	NULL
Liver	NULL
and	NULL
Pancreatic	NULL
Diseases	NULL
(	NULL
NIAAA	NULL
Grant	NULL
P-50-AA-11999	NULL
)	NULL
,	NULL
and	NULL
by	NULL
the	NULL
Andy	NULL
Barnes	NULL
Family	NULL
Foundation	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Adler	NULL
G	NULL
,	NULL
Hupp	NULL
T	NULL
,	NULL
and	NULL
Kern	NULL
HF	NULL
.	NULL

Course	NULL
and	NULL
spontaneous	NULL
regression	NULL
of	NULL
acute	NULL
pancreatitis	NULL
in	NULL
the	NULL
rat	NULL
.	NULL

Virchows	NULL
Arch	NULL
Pathol	NULL
Anat	NULL
382	NULL
:	NULL
31-47	NULL
,	NULL
1979	NULL
.	NULL

2	NULL
.	NULL

Aho	NULL
HJ	NULL
,	NULL
Koskensalo	NULL
SM	NULL
,	NULL
and	NULL
Nevalainen	NULL
TJ	NULL
.	NULL

Experimental	NULL
pancreatitis	NULL
in	NULL
the	NULL
rat	NULL
.	NULL

Sodium	NULL
taurocholate-induced	NULL
acute	NULL
hae-morrhagic	NULL
pancreatitis	NULL
.	NULL

Scand	NULL
J	NULL
Gastroenterol	NULL
15	NULL
:	NULL
411-416	NULL
,	NULL
1980	NULL
.	NULL

Downloaded	NULL
from	NULL
www.physiclogy.org/journal/ajpgi	NULL
(	NULL
173.236.240.127	NULL
)	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

NF-KB	NULL
ACTIVATION	NULL
IN	NULL
TAUROCHOLATE	NULL
PANCREATITIS	NULL
.	NULL

Baeuerle	NULL
PA	NULL
and	NULL
Baichwal	NULL
VR	NULL
.	NULL

NF-kappa	NULL
B	NULL
as	NULL
a	NULL
frequent	NULL
target	NULL
for	NULL
immunosuppressive	NULL
and	NULL
anti-inflammatory	NULL
molecules	NULL
.	NULL

Adv	NULL
Immunol	NULL
65	NULL
:	NULL
111-137	NULL
,	NULL
1997.	NULL
.	NULL

Ben-Baruch	NULL
A	NULL
,	NULL
Michiel	NULL
DF	NULL
,	NULL
and	NULL
Oppenheim	NULL
JJ	NULL
.	NULL

Signals	NULL
and	NULL
receptors	NULL
involved	NULL
in	NULL
recruitment	NULL
of	NULL
inflammatory	NULL
cells	NULL
.	NULL

J	NULL
Bio/	NULL
Chem	NULL
270	NULL
:	NULL
11703-11706	NULL
,	NULL
1995.	NULL
.	NULL

Berney	NULL
T	NULL
,	NULL
Gasche	NULL
Y	NULL
,	NULL
Robert	NULL
J	NULL
,	NULL
Jenny	NULL
A	NULL
,	NULL
Mensi	NULL
N	NULL
,	NULL
Grau	NULL
G	NULL
,	NULL
Vermeulen	NULL
B	NULL
,	NULL
and	NULL
Morel	NULL
P.	NULL
Serum	NULL
profiles	NULL
of	NULL
interleukin-6	NULL
,	NULL
interleukin-8	NULL
,	NULL
and	NULL
interleukin-10	NULL
in	NULL
patients	NULL
with	NULL
severe	NULL
and	NULL
mild	NULL
acute	NULL
pancreatitis	NULL
.	NULL

Pancreas	NULL
18	NULL
:	NULL
371-877	NULL
,	NULL
1999.	NULL
.	NULL

Bhatia	NULL
M	NULL
,	NULL
Brady	NULL
M	NULL
,	NULL
Shokuhi	NULL
S	NULL
,	NULL
Christmas	NULL
S	NULL
,	NULL
Neoptolemos	NULL
JP	NULL
,	NULL
and	NULL
Slavin	NULL
J	NULL
.	NULL

Inflammatory	NULL
mediators	NULL
in	NULL
acute	NULL
pancreatitis	NULL
.	NULL

J	NULL
Pathol	NULL
190	NULL
:	NULL
117-125	NULL
,	NULL
2000.	NULL
.	NULL

Denham	NULL
W	NULL
,	NULL
Denham	NULL
D	NULL
,	NULL
Yang	NULL
J	NULL
,	NULL
Carter	NULL
G	NULL
,	NULL
MacKay	NULL
S	NULL
,	NULL
Moldawer	NULL
LL	NULL
,	NULL
Carey	NULL
LC	NULL
,	NULL
and	NULL
Norman	NULL
J	NULL
.	NULL

Transient	NULL
human	NULL
gene	NULL
therapy	NULL
:	NULL
a	NULL
novel	NULL
cytokine	NULL
regulatory	NULL
strategy	NULL
for	NULL
experimental	NULL
pancreatitis	NULL
.	NULL

Ann	NULL
Surg	NULL
227	NULL
:	NULL
812-820	NULL
,	NULL
1998.	NULL
.	NULL

Denham	NULL
W	NULL
,	NULL
Yang	NULL
J	NULL
,	NULL
Fink	NULL
GW	NULL
,	NULL
Denham	NULL
D	NULL
,	NULL
Carter	NULL
G	NULL
,	NULL
Ward	NULL
K	NULL
,	NULL
and	NULL
Norman	NULL
J.	NULL
Gene	NULL
targeting	NULL
demonstrates	NULL
additive	NULL
detrimental	NULL
effects	NULL
of	NULL
interleukin	NULL
1	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
during	NULL
pancreatitis	NULL
.	NULL

Gastroenterology	NULL
118	NULL
:	NULL
1741-1746	NULL
,	NULL
1997.	NULL
.	NULL

Dunn	NULL
JA	NULL
,	NULL
Li	NULL
C	NULL
,	NULL
Ha	NULL
T	NULL
,	NULL
Kao	NULL
RL	NULL
,	NULL
and	NULL
Browder	NULL
W.	NULL
Therapeutic	NULL
modification	NULL
of	NULL
nuclear	NULL
factor	NULL
kappa	NULL
B	NULL
binding	NULL
activity	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor-alpha	NULL
gene	NULL
expression	NULL
during	NULL
acute	NULL
biliary	NULL
pancreatitis	NULL
.	NULL

Am	NULL
J	NULL
Surg	NULL
63	NULL
:	NULL
10836-1044	NULL
,	NULL
1997	NULL
.	NULL

Ferrara	NULL
C	NULL
,	NULL
Gress	NULL
TM	NULL
,	NULL
Mueller-Pillasch	NULL
F	NULL
,	NULL
Lutz	NULL
MP	NULL
,	NULL
Weidenbach	NULL
H	NULL
,	NULL
Poletti	NULL
A	NULL
,	NULL
Lerch	NULL
MM	NULL
,	NULL
Del	NULL
Favero	NULL
G	NULL
,	NULL
and	NULL
Adler	NULL
G.	NULL
Expression	NULL
of	NULL
the	NULL
protooncogene	NULL
jun	NULL
is	NULL
induced	NULL
in	NULL
the	NULL
rat	NULL
pancreas	NULL
by	NULL
cerulein	NULL
infusion	NULL
.	NULL

Pancreas	NULL
15	NULL
:	NULL
160-167	NULL
,	NULL
1997	NULL
.	NULL

Fink	NULL
GW	NULL
and	NULL
Norman	NULL
JG	NULL
.	NULL

Specific	NULL
changes	NULL
in	NULL
the	NULL
pancreatic	NULL
expression	NULL
of	NULL
the	NULL
interleukin	NULL
1	NULL
family	NULL
of	NULL
genes	NULL
during	NULL
experimental	NULL
acute	NULL
pancreatitis	NULL
.	NULL

Cyfokine	NULL
9	NULL
:	NULL
1023-1027	NULL
,	NULL
1997	NULL
.	NULL

Frossard	NULL
JL	NULL
,	NULL
Saluja	NULL
AK	NULL
,	NULL
Bhagat	NULL
L	NULL
,	NULL
Lee	NULL
HS	NULL
,	NULL
Bhatia	NULL
M	NULL
,	NULL
Hofbauer	NULL
B	NULL
,	NULL
and	NULL
Steer	NULL
ML	NULL
.	NULL

The	NULL
role	NULL
of	NULL
intercellular	NULL
adhesion	NULL
molecule	NULL
1	NULL
and	NULL
neutrophils	NULL
in	NULL
acute	NULL
pancreatitis	NULL
and	NULL
pancreati-tis-associated	NULL
lung	NULL
injury	NULL
.	NULL

Gastroenterology	NULL
116	NULL
:	NULL
694-701	NULL
,	NULL
1999	NULL
.	NULL

Fu	NULL
K	NULL
,	NULL
Sarras	NULL
MPJ	NULL
,	NULL
De	NULL
Lisle	NULL
RC	NULL
,	NULL
and	NULL
Andrews	NULL
GK	NULL
.	NULL

Expression	NULL
of	NULL
oxidative	NULL
stress-responsive	NULL
genes	NULL
and	NULL
cytokine	NULL
genes	NULL
during	NULL
caerulein-induced	NULL
acute	NULL
pancreatitis	NULL
.	NULL

Am	NULL
J	NULL
Physiol	NULL
Gastrointest	NULL
Liver	NULL
Physiol	NULL
278	NULL
:	NULL
G6I6-G705	NULL
,	NULL
1997	NULL
.	NULL

Ghosh	NULL
S	NULL
,	NULL
May	NULL
MJ	NULL
,	NULL
and	NULL
Kopp	NULL
EB	NULL
.	NULL

NF-kappa	NULL
B	NULL
and	NULL
Rel	NULL
pro-teins	NULL
:	NULL
evolutionarily	NULL
conserved	NULL
mediators	NULL
of	NULL
immune	NULL
responses	NULL
.	NULL

Annu	NULL
Rev	NULL
Immunol	NULL
16	NULL
:	NULL
225-260	NULL
,	NULL
1998	NULL
.	NULL

Gius	NULL
D	NULL
,	NULL
Botero	NULL
A	NULL
,	NULL
Shah	NULL
S	NULL
,	NULL
and	NULL
Curry	NULL
HA	NULL
.	NULL

Intracellular	NULL
oxidation/reduction	NULL
status	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
transcription	NULL
factors	NULL
NF-kappaB	NULL
and	NULL
AP-1	NULL
.	NULL

Toxicol	NULL
Lett	NULL
106	NULL
:	NULL
98-106	NULL
,	NULL
1999	NULL
.	NULL

Gukovskaya	NULL
AS	NULL
,	NULL
Gukovsky	NULL
I	NULL
,	NULL
Zaninovic	NULL
V	NULL
,	NULL
Song	NULL
M	NULL
,	NULL
Sandoval	NULL
D	NULL
,	NULL
Gukovsky	NULL
AS	NULL
,	NULL
and	NULL
Pandol	NULL
SJ	NULL
.	NULL

Pancreatic	NULL
acinar	NULL
cells	NULL
produce	NULL
,	NULL
release	NULL
,	NULL
and	NULL
respond	NULL
to	NULL
tumor	NULL
necrosis	NULL
factor-	NULL
«	NULL
.	NULL

Role	NULL
in	NULL
regulating	NULL
cell	NULL
death	NULL
and	NULL
pancreatitis	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
100	NULL
:	NULL
1853-1862	NULL
,	NULL
1997	NULL
.	NULL

Gukovsky	NULL
I	NULL
,	NULL
Gukovskaya	NULL
AS	NULL
,	NULL
Blinman	NULL
TA	NULL
,	NULL
Zaninovic	NULL
V	NULL
,	NULL
and	NULL
Pandol	NULL
SJ	NULL
.	NULL

Early	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
is	NULL
associated	NULL
with	NULL
hormone-induced	NULL
pancreatitis	NULL
.	NULL

Am	NULL
J	NULL
Physiol	NULL
Gastrointest	NULL
Liver	NULL
Physiol	NULL
275	NULL
:	NULL
G1402-G1414	NULL
,	NULL
1998	NULL
.	NULL

Halme	NULL
L	NULL
,	NULL
Doepel	NULL
M	NULL
,	NULL
von	NULL
Numers	NULL
H	NULL
,	NULL
Edgren	NULL
J	NULL
,	NULL
and	NULL
Ahonen	NULL
J	NULL
.	NULL

Complications	NULL
of	NULL
diagnostic	NULL
and	NULL
therapeutic	NULL
ERCP	NULL
.	NULL

Ann	NULL
Chir	NULL
Gynaecol	NULL
88	NULL
:	NULL
127-131	NULL
,	NULL
1999	NULL
.	NULL

Han	NULL
B	NULL
and	NULL
Logsdon	NULL
CD	NULL
.	NULL

Cholecystokinin	NULL
induction	NULL
of	NULL
mob-1	NULL
chemokine	NULL
expression	NULL
in	NULL
pancreatic	NULL
acinar	NULL
cells	NULL
requires	NULL
NF-kappaB	NULL
activation	NULL
.	NULL

Am	NULL
J	NULL
Physiol	NULL
Cell	NULL
Physiol	NULL
277	NULL
:	NULL
C74-C82	NULL
,	NULL
1999	NULL
.	NULL

Heath	NULL
DI	NULL
,	NULL
Cruickshank	NULL
A	NULL
,	NULL
Gudgeon	NULL
M	NULL
,	NULL
Jehanli	NULL
A	NULL
,	NULL
Shenkin	NULL
A	NULL
,	NULL
and	NULL
Imrie	NULL
CW	NULL
.	NULL

Role	NULL
of	NULL
interleukin-6	NULL
in	NULL
mediating	NULL
the	NULL
acute	NULL
phase	NULL
protein	NULL
response	NULL
and	NULL
potential	NULL
as	NULL
an	NULL
early	NULL
means	NULL
of	NULL
severity	NULL
assessment	NULL
in	NULL
acute	NULL
pancreatitis	NULL
.	NULL

Gut	NULL
34	NULL
:	NULL
41-45	NULL
,	NULL
1998	NULL
.	NULL

Hughes	NULL
CB	NULL
,	NULL
Grewal	NULL
HP	NULL
,	NULL
Gaber	NULL
LW	NULL
,	NULL
Kotb	NULL
M	NULL
,	NULL
El-din	NULL
AB	NULL
,	NULL
Mann	NULL
L	NULL
,	NULL
and	NULL
Gaber	NULL
AO	NULL
.	NULL

Anti-TNF	NULL
alpha	NULL
therapy	NULL
improves	NULL
survival	NULL
and	NULL
ameliorates	NULL
the	NULL
patholphysiologic	NULL
sequelae	NULL
in	NULL
acute	NULL
pancreatitis	NULL
in	NULL
the	NULL
rat	NULL
.	NULL

Am	NULL
J	NULL
Surg	NULL
171	NULL
:	NULL
274-280	NULL
,	NULL
1996	NULL
.	NULL

Karin	NULL
M	NULL
,	NULL
Liu	NULL
Z	NULL
,	NULL
and	NULL
Zandi	NULL
E.	NULL
AP-1	NULL
function	NULL
and	NULL
regulation	NULL
.	NULL

Curr	NULL
Opin	NULL
Cell	NULL
Biol	NULL
9	NULL
:	NULL
240-246	NULL
,	NULL
1997	NULL
.	NULL

Kawabata	NULL
S	NULL
,	NULL
Miura	NULL
T	NULL
,	NULL
Morita	NULL
T	NULL
,	NULL
Kato	NULL
H	NULL
,	NULL
Fujikawa	NULL
K	NULL
,	NULL
Iwanaga	NULL
S	NULL
,	NULL
Takada	NULL
T	NULL
,	NULL
Kimura	NULL
T	NULL
,	NULL
and	NULL
Sakakibara	NULL
S.	NULL
Highly	NULL
24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

G1207	NULL
sensitive	NULL
peptide-4-methylcoumaryl-7-amide	NULL
substrates	NULL
for	NULL
blood-clotting	NULL
proteases	NULL
and	NULL
trypsin	NULL
.	NULL

Eur	NULL
J	NULL
Biochem	NULL
172	NULL
;	NULL
17-25	NULL
,	NULL
1988	NULL
.	NULL

Kingsnorth	NULL
A	NULL
.	NULL

Role	NULL
of	NULL
cytokines	NULL
and	NULL
their	NULL
inhibitors	NULL
in	NULL
acute	NULL
pancreatitis	NULL
.	NULL

Gut	NULL
40	NULL
:	NULL
1-4	NULL
,	NULL
1997	NULL
.	NULL

Kusterer	NULL
K	NULL
,	NULL
Enghofer	NULL
M	NULL
,	NULL
Zendler	NULL
S	NULL
,	NULL
Blochle	NULL
C	NULL
,	NULL
and	NULL
Usadel	NULL
KH	NULL
.	NULL

Microcirculatory	NULL
changes	NULL
in	NULL
sodium	NULL
taurocholate-induced	NULL
pancreatitis	NULL
in	NULL
rats	NULL
.	NULL

Am	NULL
J	NULL
Physiol	NULL
Gastrointest	NULL
Liver	NULL
Physiol	NULL
260	NULL
:	NULL
G346-GS351	NULL
,	NULL
1991	NULL
.	NULL

Lampel	NULL
M	NULL
and	NULL
Kern	NULL
HF	NULL
.	NULL

Acute	NULL
interstitial	NULL
pancreatitis	NULL
in	NULL
the	NULL
rat	NULL
induced	NULL
by	NULL
excessive	NULL
doses	NULL
of	NULL
a	NULL
pancreatic	NULL
secretagogue	NULL
.	NULL

Virchows	NULL
Arch	NULL
Pathol	NULL
Anat	NULL
373	NULL
:	NULL
97-117	NULL
,	NULL
1977	NULL
.	NULL

Lankisch	NULL
PG	NULL
and	NULL
Ihse	NULL
I.	NULL
Bile-induced	NULL
acute	NULL
experimental	NULL
pancreatitis	NULL
.	NULL

Scand	NULL
J	NULL
Gastroenterol	NULL
22	NULL
:	NULL
257-260	NULL
,	NULL
1987	NULL
.	NULL

Leser	NULL
HG	NULL
,	NULL
Gross	NULL
V	NULL
,	NULL
Scheibenbogen	NULL
C	NULL
,	NULL
Heinisch	NULL
A	NULL
,	NULL
Salm	NULL
R	NULL
,	NULL
Lausen	NULL
M	NULL
,	NULL
Ruckauer	NULL
K	NULL
,	NULL
Andreesen	NULL
R	NULL
,	NULL
Farthmann	NULL
EH	NULL
,	NULL
and	NULL
Scholmerich	NULL
J.	NULL
Elevation	NULL
of	NULL
serum	NULL
interleukin-6	NULL
concentration	NULL
precedes	NULL
acute-phase	NULL
response	NULL
and	NULL
reflects	NULL
severity	NULL
in	NULL
acute	NULL
pancreatitis	NULL
.	NULL

Gastroenterology	NULL
101	NULL
:	NULL
782-785	NULL
,	NULL
1991	NULL
.	NULL

Loperfido	NULL
S	NULL
,	NULL
Angelini	NULL
G	NULL
,	NULL
Chilovi	NULL
F	NULL
,	NULL
Costan	NULL
F	NULL
,	NULL
De	NULL
Berardi-nis	NULL
F	NULL
,	NULL
Bernardin	NULL
M	NULL
,	NULL
Ederle	NULL
A	NULL
,	NULL
Fina	NULL
P	NULL
,	NULL
and	NULL
Fratton	NULL
A	NULL
.	NULL

Major	NULL
early	NULL
complications	NULL
from	NULL
diagnostic	NULL
and	NULL
therapeutic	NULL
ERCP	NULL
:	NULL
a	NULL
prospective	NULL
multicenter	NULL
study	NULL
.	NULL

Gastrointest	NULL
Endosc	NULL
48	NULL
:	NULL
1-10	NULL
,	NULL
1998	NULL
.	NULL

Luster	NULL
AD	NULL
.	NULL

Chemokines-chemotactic	NULL
cytokines	NULL
that	NULL
mediate	NULL
inflammation	NULL
.	NULL

N	NULL
Eng	NULL
!	NULL

J	NULL
Med	NULL
338	NULL
:	NULL
486-445	NULL
,	NULL
1998	NULL
.	NULL

Luthen	NULL
R	NULL
,	NULL
Grendell	NULL
JH	NULL
,	NULL
Niederau	NULL
C	NULL
,	NULL
and	NULL
Haussinger	NULL
D.	NULL
Trypsinogen	NULL
activation	NULL
and	NULL
glutathione	NULL
content	NULL
are	NULL
linked	NULL
to	NULL
pancreatic	NULL
injury	NULL
in	NULL
models	NULL
of	NULL
biliary	NULL
acute	NULL
pancreatitis	NULL
.	NULL

Int	NULL
J	NULL
Pancreatol	NULL
24	NULL
:	NULL
198-202	NULL
,	NULL
1998	NULL
.	NULL

Luthen	NULL
R	NULL
,	NULL
Niederau	NULL
C	NULL
,	NULL
Niederau	NULL
M	NULL
,	NULL
Ferrell	NULL
LD	NULL
,	NULL
and	NULL
Grendell	NULL
JH	NULL
.	NULL

Influence	NULL
of	NULL
ductal	NULL
pressure	NULL
and	NULL
infusates	NULL
on	NULL
activity	NULL
and	NULL
subcellular	NULL
distribution	NULL
of	NULL
lysosomal	NULL
enzymes	NULL
in	NULL
the	NULL
rat	NULL
pancreas	NULL
.	NULL

Gastroenterology	NULL
109	NULL
:	NULL
578-581	NULL
,	NULL
1995	NULL
.	NULL

Marks-Konezalik	NULL
J	NULL
,	NULL
Chu	NULL
SC	NULL
,	NULL
and	NULL
Moss	NULL
J.	NULL
Cytokine-mediated	NULL
transcriptional	NULL
induction	NULL
of	NULL
the	NULL
human	NULL
inducible	NULL
nitric	NULL
oxide	NULL
synthase	NULL
gene	NULL
requires	NULL
both	NULL
activator	NULL
protein	NULL
1	NULL
and	NULL
nuclear	NULL
factor	NULL
kappaB-binding	NULL
sites	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
278	NULL
:	NULL
22201-22208	NULL
,	NULL
1998	NULL
.	NULL

Martin	NULL
T	NULL
,	NULL
Cardarelli	NULL
PM	NULL
,	NULL
Parry	NULL
GC	NULL
,	NULL
Felts	NULL
KA	NULL
,	NULL
and	NULL
Cobb	NULL
RKR	NULL
.	NULL

Cytokine	NULL
induction	NULL
of	NULL
monocyte	NULL
chemoattractant	NULL
protein-1	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
endothelial	NULL
cells	NULL
depends	NULL
on	NULL
the	NULL
cooperative	NULL
action	NULL
of	NULL
NF-kappa	NULL
B	NULL
and	NULL
AP-1	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
27	NULL
:	NULL
1091-1097	NULL
,	NULL
1997	NULL
.	NULL

Molero	NULL
X	NULL
,	NULL
Guarner	NULL
F	NULL
,	NULL
Salas	NULL
A	NULL
,	NULL
Mourelle	NULL
M	NULL
,	NULL
Puig	NULL
V	NULL
,	NULL
and	NULL
Malagelada	NULL
JR.	NULL
Nitric	NULL
oxide	NULL
modulates	NULL
pancreatic	NULL
basal	NULL
secretion	NULL
and	NULL
response	NULL
to	NULL
cerulein	NULL
in	NULL
the	NULL
rat	NULL
:	NULL
effects	NULL
in	NULL
acute	NULL
pancreatitis	NULL
.	NULL

Gastroenterology	NULL
108	NULL
:	NULL
1855-1862	NULL
,	NULL
1995	NULL
.	NULL

Norman	NULL
J	NULL
.	NULL

The	NULL
role	NULL
of	NULL
cytokines	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
acute	NULL
pancreatitis	NULL
.	NULL

Am	NULL
J	NULL
Surg	NULL
175	NULL
:	NULL
76-83	NULL
,	NULL
1998	NULL
.	NULL

Norman	NULL
J	NULL
,	NULL
Franz	NULL
MG	NULL
,	NULL
Messina	NULL
J	NULL
,	NULL
Riker	NULL
A	NULL
,	NULL
Fabri	NULL
PJ	NULL
,	NULL
Rose-murgy	NULL
AS	NULL
,	NULL
and	NULL
Gower	NULL
WRJ	NULL
.	NULL

Interleukin-1	NULL
receptor	NULL
antagonist	NULL
decreases	NULL
severity	NULL
of	NULL
experimental	NULL
acute	NULL
pancreatitis	NULL
.	NULL

Surgery	NULL
117	NULL
:	NULL
648-655	NULL
,	NULL
1995	NULL
.	NULL

Norman	NULL
JG	NULL
,	NULL
Fink	NULL
GW	NULL
,	NULL
and	NULL
Franz	NULL
MG	NULL
.	NULL

Acute	NULL
pancreatitis	NULL
induces	NULL
intrapancreatic	NULL
tumor	NULL
necrosis	NULL
factor	NULL
gene	NULL
expression	NULL
.	NULL

Arch	NULL
Surg	NULL
130	NULL
:	NULL
966-970	NULL
,	NULL
1995	NULL
.	NULL

Pandol	NULL
SJ	NULL
,	NULL
Periskic	NULL
S	NULL
,	NULL
Gukovsky	NULL
I	NULL
,	NULL
Zaninovic	NULL
V	NULL
,	NULL
Jung	NULL
Y	NULL
,	NULL
Zong	NULL
Y	NULL
,	NULL
Solomon	NULL
TE	NULL
,	NULL
Gukovskaya	NULL
AS	NULL
,	NULL
and	NULL
Tsukamoto	NULL
H.	NULL
Ethanol	NULL
diet	NULL
increases	NULL
the	NULL
sensitivity	NULL
of	NULL
rats	NULL
to	NULL
pancreatitis	NULL
induced	NULL
by	NULL
cholecystokinin	NULL
octapeptide	NULL
.	NULL

Gastroenterology	NULL
117	NULL
:	NULL
706-716	NULL
,	NULL
1999	NULL
.	NULL

Roebuck	NULL
KA	NULL
,	NULL
Carpenter	NULL
LR	NULL
,	NULL
Lakshminarayanan	NULL
V	NULL
,	NULL
Page	NULL
SM	NULL
,	NULL
Moy	NULL
JN	NULL
,	NULL
and	NULL
Thomas	NULL
LL	NULL
.	NULL

Stimulus-specific	NULL
regulation	NULL
of	NULL
chemokine	NULL
expression	NULL
involves	NULL
differential	NULL
activation	NULL
of	NULL
the	NULL
re-dox-responsive	NULL
transcription	NULL
factors	NULL
AP-1	NULL
and	NULL
NF-kappaB	NULL
.	NULL

J	NULL
Leukoc	NULL
Biol	NULL
65	NULL
:	NULL
291-298	NULL
,	NULL
1999	NULL
.	NULL

Sandoval	NULL
D	NULL
,	NULL
Gukovskaya	NULL
AS	NULL
,	NULL
Reavey	NULL
P	NULL
,	NULL
Gukovsky	NULL
S	NULL
,	NULL
Sisk	NULL
A	NULL
,	NULL
Braquet	NULL
P	NULL
,	NULL
Pandol	NULL
SJ	NULL
,	NULL
and	NULL
Poucell-Hatton	NULL
S.	NULL
The	NULL
role	NULL
of	NULL
neutrophils	NULL
and	NULL
platelet-activating	NULL
factor	NULL
in	NULL
mediating	NULL
experimental	NULL
pancreatitis	NULL
.	NULL

Gastroenterology	NULL
111	NULL
:	NULL
1081-1091	NULL
,	NULL
1996	NULL
.	NULL

Satoh	NULL
A	NULL
,	NULL
Shimosegawa	NULL
T	NULL
,	NULL
Fujita	NULL
M	NULL
,	NULL
Kimura	NULL
K	NULL
,	NULL
Masamune	NULL
A	NULL
,	NULL
Koizumi	NULL
M	NULL
,	NULL
and	NULL
Toyota	NULL
T.	NULL
Inhibition	NULL
of	NULL
nuclear	NULL
factor	NULL
Downloaded	NULL
from	NULL
www.physiclogy.org/journal/ajpgi	NULL
(	NULL
173.236.240.127	NULL
)	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

G1208	NULL
43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47.	NULL
kappaB	NULL
activation	NULL
improves	NULL
the	NULL
survival	NULL
of	NULL
rats	NULL
with	NULL
taurocholate	NULL
pancreatitis	NULL
.	NULL

Gut	NULL
44	NULL
:	NULL
253-258	NULL
,	NULL
1999	NULL
.	NULL

Schmid	NULL
RM	NULL
and	NULL
Adler	NULL
G.	NULL
Cytokines	NULL
in	NULL
acute	NULL
pancreatitis-new	NULL
pathophysiclogical	NULL
concepts	NULL
evolve	NULL
.	NULL

Eur	NULL
J	NULL
Gastroenterol	NULL
Hepatol	NULL
11	NULL
:	NULL
125-127	NULL
,	NULL
1999	NULL
.	NULL

Steinle	NULL
AU	NULL
,	NULL
Weidenbach	NULL
H	NULL
,	NULL
Wagner	NULL
M	NULL
,	NULL
Adler	NULL
G	NULL
,	NULL
and	NULL
Schmid	NULL
RM	NULL
.	NULL

NF-	NULL
«	NULL
B/Rel	NULL
activation	NULL
in	NULL
cerulein	NULL
pancreatitis	NULL
.	NULL

Gastroenterology	NULL
116	NULL
:	NULL
420-4830	NULL
,	NULL
1999	NULL
.	NULL

Telek	NULL
G	NULL
,	NULL
Scoazec	NULL
JY	NULL
,	NULL
Chariot	NULL
J	NULL
,	NULL
Ducroc	NULL
R	NULL
,	NULL
Feldmann	NULL
G	NULL
,	NULL
and	NULL
Roz	NULL
C.	NULL
Cerium-based	NULL
histochemical	NULL
demonstration	NULL
of	NULL
oxidative	NULL
stress	NULL
in	NULL
taurocholate-induced	NULL
acute	NULL
pancreatitis	NULL
in	NULL
rats	NULL
.	NULL

A	NULL
confocal	NULL
laser	NULL
scanning	NULL
microscopic	NULL
study	NULL
.	NULL

J	NULL
Histochem	NULL
Cyto-chem	NULL
47	NULL
:	NULL
1201-1212	NULL
,	NULL
1999	NULL
.	NULL

Werner	NULL
J	NULL
,	NULL
Dragotakes	NULL
SC	NULL
,	NULL
Fernandez-del	NULL
Castillo	NULL
C	NULL
,	NULL
Rivera	NULL
J	NULL
,	NULL
Ou	NULL
J	NULL
,	NULL
Rattner	NULL
DW	NULL
,	NULL
Fischman	NULL
AJ	NULL
,	NULL
and	NULL
Warshaw	NULL
AL	NULL
.	NULL

Technetium-99m-labeled	NULL
white	NULL
blood	NULL
cells	NULL
:	NULL
a	NULL
new	NULL
method	NULL
to	NULL
define	NULL
the	NULL
local	NULL
and	NULL
systemic	NULL
role	NULL
of	NULL
leukocytes	NULL
in	NULL
acute	NULL
experimental	NULL
pancreatitis	NULL
.	NULL

Ann	NULL
Surg	NULL
227	NULL
:	NULL
86-94	NULL
,	NULL
1998	NULL
.	NULL

Werner	NULL
J	NULL
,	NULL
Rivera	NULL
J	NULL
,	NULL
Fernandez-del	NULL
Castillo	NULL
C	NULL
,	NULL
Lewan-drowski	NULL
KB	NULL
,	NULL
Adrie	NULL
C	NULL
,	NULL
Rattner	NULL
DW	NULL
,	NULL
and	NULL
Warshaw	NULL
AL	NULL
.	NULL

Dif-	NULL
48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

NF-KB	NULL
ACTIVATION	NULL
IN	NULL
TAUROCHOLATE	NULL
PANCREATITIS	NULL
fering	NULL
roles	NULL
of	NULL
nitric	NULL
oxide	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
acute	NULL
edema-tous	NULL
versus	NULL
necrotizing	NULL
pancreatitis	NULL
.	NULL

Surgery	NULL
12	NULL
:	NULL
28-30	NULL
,	NULL
1997	NULL
.	NULL

Werner	NULL
J	NULL
,	NULL
7graggen	NULL
K	NULL
,	NULL
Fernandez-del	NULL
Castillo	NULL
C	NULL
,	NULL
Lewand-rowski	NULL
KB	NULL
,	NULL
Compton	NULL
CC	NULL
,	NULL
and	NULL
Warshaw	NULL
AL	NULL
.	NULL

Specific	NULL
therapy	NULL
for	NULL
local	NULL
and	NULL
systemic	NULL
complications	NULL
of	NULL
acute	NULL
pancreatitis	NULL
with	NULL
monoclonal	NULL
antibodies	NULL
against	NULL
ICAM-1	NULL
.	NULL

Ann	NULL
Surg	NULL
229	NULL
:	NULL
834-840	NULL
,	NULL
1999	NULL
.	NULL

Whitmarsh	NULL
AJ	NULL
and	NULL
Davis	NULL
RJ	NULL
.	NULL

Transcription	NULL
factor	NULL
AP-1	NULL
regulation	NULL
by	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
signal	NULL
transduction	NULL
pathways	NULL
.	NULL

Mol	NULL
Med	NULL
74	NULL
:	NULL
589-607	NULL
,	NULL
1996	NULL
.	NULL

Wisdom	NULL
R.	NULL
AP-1	NULL
:	NULL
one	NULL
switch	NULL
for	NULL
many	NULL
signals	NULL
.	NULL

Exp	NULL
Cell	NULL
Res	NULL
253	NULL
:	NULL
180-185	NULL
,	NULL
1999	NULL
.	NULL

Wulezyn	NULL
FG	NULL
,	NULL
Krappmann	NULL
D	NULL
,	NULL
and	NULL
Scheidereit	NULL
C.	NULL
The	NULL
NF-	NULL
«	NULL
xB/	NULL
Rel	NULL
and	NULL
I-	NULL
«	NULL
B	NULL
gene	NULL
families	NULL
:	NULL
mediators	NULL
of	NULL
immune	NULL
response	NULL
and	NULL
inflammation	NULL
.	NULL

J	NULL
Mol	NULL
Med	NULL
74	NULL
:	NULL
749-769	NULL
,	NULL
1996	NULL
.	NULL

Zaninovic	NULL
V	NULL
,	NULL
Gukovskaya	NULL
AS	NULL
,	NULL
Gukovsky	NULL
I	NULL
,	NULL
Mouria	NULL
M	NULL
,	NULL
and	NULL
Pandol	NULL
SJ	NULL
.	NULL

Cerulein	NULL
upregulates	NULL
ICAM-1	NULL
in	NULL
pancreatic	NULL
acinar	NULL
cells	NULL
,	NULL
which	NULL
mediates	NULL
neutrophil	NULL
adhesion	NULL
to	NULL
these	NULL
cells	NULL
.	NULL

Am	NULL
J	NULL
Physiol	NULL
Gastrointest	NULL
Liver	NULL
Physiol	NULL
279	NULL
:	NULL
G66G-G676	NULL
,	NULL
2000	NULL
.	NULL

Downloaded	NULL
from	NULL
www.physiclogy.org/journal/ajpgi	NULL
(	NULL
173.236.240.127	NULL
)	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

